Podcasts about IND

Histórias de quem torce e de quem corneta. No primeiro ato: a água da sarjeta mostra o caminho. Por Maíra Vallejo. No segundo ato: revolucionários do Brasil, uni-vos: para secar a seleção brasileira. Por Vitor Hugo Brandalise. Membros do Clube da Novelo podem ouvir os episódios do Rádio Novelo Apresenta antecipadamente, além de ter acesso a uma newsletter especial e a eventos com a nossa equipe. Quem assinar o plano anual ganha de brinde uma bolsa da Novelo. Assine em ⁠⁠⁠https://clube.radionovelo.com.br/ Inscreva-se no canal da Rádio Novelo no YouTube: https://www.youtube.com/@R%C3%A1dioNovelo Siga a Rádio Novelo no Instagram: https://www.instagram.com/radionovelo/ A segunda temporada do podcast “Em Obras” chegou! O que uma obra de arte da 36ª Bienal de São Paulo tem a ver com a vida da gente? Descubra em conversas com nomes como Itamar Vieira Junior, Maria Homem, Milly Lacombe e Michel Melamed, com narração de Xênia França. Novos episódios estreiam toda sexta-feira. O projeto é uma coprodução do UOL com a Fundação Bienal de São Paulo, e foi realizado com apoio do Programa de Ação Cultural — ProAC, da Secretaria da Cultura, Economia e Indústria Criativas do Governo do Estado de São Paulo. Insider: tecnologia aplicada à rotina – peças que desamassam no corpo, facilitam a evaporação do suor e seguem confortáveis por horas. Utilize o cupom RADIONOVELO e tenha 15% OFF na 1ª compra e 10% OFF nas próximas – e ainda soma com os descontos do site. https://creators.insiderstore.com.br/RADIONOVELO #insiderstore Palavras-chave: corrida de tampinhas; futebol; Copa do Mundo; Seleção brasileira; previsão; Copa 1970; luta armada; esquerda brasileira; ditadura militar Learn more about your ad choices. Visit megaphone.fm/adchoices

In the Best of the Bears this week, Laurence Holmes and Russ Dorsey discussed how defensive coordinator Dennis Allen is under the microscope with the task of improving a unit that didn't add a difference-making pass rusher in the offseason; Matt Spiegel and Holmes reacted to a report that the Bears' proposed stadium in Hammond, Ind. would be built on a slag heap; and Palatine mayor Jim Schwantz joined the Mully & Haugh Show to discuss the effects on his community of the Bears potentially building a new stadium in Arlington Heights.

In the Best of the Bears this week, Laurence Holmes and Russ Dorsey discussed how defensive coordinator Dennis Allen is under the microscope with the task of improving a unit that didn't add a difference-making pass rusher in the offseason; Matt Spiegel and Holmes reacted to a report that the Bears' proposed stadium in Hammond, Ind. would be built on a slag heap; and Palatine mayor Jim Schwantz joined the Mully & Haugh Show to discuss the effects on his community of the Bears potentially building a new stadium in Arlington Heights.

In the Best of the Bears this week, Laurence Holmes and Russ Dorsey discussed how defensive coordinator Dennis Allen is under the microscope with the task of improving a unit that didn't add a difference-making pass rusher in the offseason; Matt Spiegel and Holmes reacted to a report that the Bears' proposed stadium in Hammond, Ind. would be built on a slag heap; and Palatine mayor Jim Schwantz joined the Mully & Haugh Show to discuss the effects on his community of the Bears potentially building a new stadium in Arlington Heights.

De president van de Algemene Rekenkamer, Pieter Duisenberg, presenteerde deze week zijn jaarlijkse verantwoordingsonderzoek over de €450 miljard euro die de rijksoverheid uitgeeft. Met deze keer daarbij ook een ‘hoogrisicolijst'. Zo kunnen Kamers en kabinet zélf zien bij welke grote beleidsthema's politieke, economische en maatschappelijke doelen op lange termijn voortgang gemaakt wordt en waar het stagneert of zelfs spaak loopt. In gesprek met Jaap Jansen en PG Kroeger stelt hij: "Belangrijke doelen raken uit zicht. En zelfs doelen voor de korte termijn. Dat is kostbare stilstand, want niks doen veroorzaakt extra kosten en tegenvallers in de jaren die komen. Stagnatie is nooit gratis." *** Deze aflevering is mede mogelijk gemaakt met donaties van luisteraars die we hiervoor hartelijk danken. Word ook vriend van de show! in deze aflevering: vijf prijswinnaars van het boek van Paul Frissen, met dank aan uitgeverij Boom Heb je belangstelling om in onze podcast te adverteren of ons te sponsoren? Zend ons een mailtje en wij zoeken contact. *** Uit de hooggestemde plannen en geringe prestaties van het kabinet-Schoof trekt Duisenberg de conclusie dat een realistische overheid wenselijk en noodzakelijk is. Een overheid die duidelijk is over ambities en daar doelstellingen bij formuleert. Die ook realistisch aangeeft 'dit kan en dat dan dus niet'. Die slagvaardigheid en eenvoud vooropzet door te werken met taskforces die verkokering doorbreken en daarmee doorbraken mogelijk maakt, die al te lang op zich laten wachten. De aanzet met zulke taskforces in het kabinet-Jetten biedt perspectief. De Rekenkamer biedt hen dan ook gretig handreikingen voor het 'realistisch plannen' van beleid en voor duidelijkheid bij de doelen die zij nastreven. Een helder onderscheid in begrotingen tussen kasuitgaven en investeringen. Nu loopt dat allemaal door elkaar heen: “Een beetje zoals een student zijn studiebeurs gebruikt." In die 'hoogrisicolijst' staat de houdbaarheid van de overheidsfinanciën zelf op 1. Duisenberg kan zijn irritatie niet onderdrukken over het gebrek aan politieke moed. Ondoelmatige fiscale regelingen - die dus niet doen waarvoor ze bedoeld zijn – belopen inmiddels € 89 miljard. Sanering daarvan levert € 35 miljard op. En dat zou ook nog eens meteen het veel te complexe belastingstelsel vereenvoudigen. Voorstellen voor sanering liggen al een tijd op tafel. "Maar hier gebeurt niks, terwijl grote opgaven wachten op doorbraken en lange termijn investeringen." Bij het woningtekort noteert hij dat de helft van het geld dat beschikbaar was voor woningbouw, ook voor een extra snelle aanpak via flexwoningen, op de plank is blijven liggen. "Hierdoor is het tekort aan huizen nog verder vergroot." Bij het stikstofbeleid heeft het vooruitschuiven van beslissingen grote gevolgen. "De maatschappelijke kosten zijn zo'n € 15 miljard per jaar waarin geen concreet beleid wordt ingezet. Het kabinet kwam zijn beloften niet na." Bij de voorgenomen krimp van de rijksoverheid noemt Duisenberg de uitkomst teleurstellend. Het kabinet-Schoof wilde in het coalitieakkoord 22% minder ambtenaren. Dat werd vertaald naar ‘een kaasschaaf-operatie’ van € 1 miljard. “Een plan voor de lange termijn is niet bekend. Wij zien geen sturing door de minister van BZK”, noteert de Rekenkamer droog. Minister Pieter Heerma moet opnieuw beginnen. Bij de Wajong-uitkeringen kan voor 1 op de 8 dossiers - binnen een bedrag van ruim 4 miljard - niet vastgesteld worden of de uitgaven rechtmatig zijn. "De minister van Sociale Zaken heeft niet het inzicht in de omvang en onzekerheden daarvoor." Duisenberg benadrukt dat op allerlei beleidsterreinen wel degelijk voortgang is geboekt. 5000 mensen erbij in de Nationale Zorgreserve bewijst dat, evenals de enorme krachtsinspanning bij nieuwe investeringen in Defensie. Toch gaat juist bij de nationale veiligheidsstrategie nog te veel mis. "Er is geen fraude- en anti-corruptiebeleid daar, gelet op die grote investeringen is dit een zorgelijk feit", terwijl de beveiliging van grote militaire objecten nog steeds niet op orde is. "Het Rijk is in een aantal opzichten nog niet klaar voor een acute toename van dreiging." Bij de bescherming van infrastructuur op de Noordzee komt dat door verkokering en ‘bestuurlijke impasse’. Bij de screening door de IND op terrorisme blijkt 'het strengste asielbeleid ooit' niet binnen de beloofde twee weken, maar pas binnen twee jaar te kunnen leveren. Volgens de Rekenkamer laten beide Kamers nog heel wat kansen laten liggen om hun parlementaire bevoegdheden en controletaken goed te benutten. Van de vele gedegen evaluaties door wordt weinig gebruik gemaakt. Voor de nieuwe taskforces van het kabinet zouden Tweede-Kamercommissies minder verkokerd moeten opereren. "We hebben een lerende overheid nodig. Successen uit het verleden kunnen ons inspireren. Hoe Thorbecke zo'n enorm project als de Nieuwe Waterweg en het Noordzeekanaal tot stand wist te brengen. Dat koste zes keer meer dan begroot, maar het levert ons nog steeds welvaart op. En toen niet alles meteen lukte was er geen afrekencultuur, maar werd scherp geanalyseerd wat er mis ging en daar leerden ze van.” *** Verder lezen Het rapport van de Rekenkamer En de bijlagen *** Verder luisteren 547 – Knopen doorhakken, hervormen en stevig investeren: het formatie-advies van Jeroen Dijsselbloem en Pieter Duisenberg 554 - Vooruit durven kijken, net als 50 jaar geleden met Almere 533 – Een nieuw belastingstelsel. Leuker kunnen we het niet maken, eenvoudiger wel 507 - Het strenge oordeel van Rekenkamerpresident Pieter Duisenberg 446 - Doe wat Draghi zegt of Europa wacht een langzame doodsstrijd 423 – Eerst zien, dan geloven – Rekenkamerpresident Pieter Duisenberg over de controle op de rijksuitgaven 274 - Thorbecke, denker en doener 210 - Herman Tjeenk Willink over het verval van de democratische rechtsorde 208 - Max Weber: wetenschap als beroep en politiek als beroep 120 - Roel Bekker: Waarom bij de overheid dingen zo vaak fout gaan *** Tijdlijn 00:00:00 – Deel 1 00:28: 41 – Deel 2 01:05:56 – Deel 3 01:24:00 – EindeSee omnystudio.com/listener for privacy information.

Matt Spiegel and Laurence Holmes welcomed on Cubs second baseman Nico Hoerner to discuss a wide variety of topics and reacted to concerning new reporting on the Bears' proposed site for a new stadium in Hammond, Ind.

In the third hour, Matt Spiegel and Laurence Holmes had fun with the latest developments and details surrounding the Bears' proposed stadium site in Hammond, Ind. It doesn't sound like a good place to build a state-of-the-art stadium, to say the least. After that, the guys listened and reacted to Palatine mayor Jim Schwantz's comments on the Mully & Haugh Show about him wanting the Bears to provide a traffic and impact study for his community regarding the effects of potentially building a new stadium in Arlington Heights.

Dans cet épisode, on parle de comment construire une vie qui sort vraiment de l'ordinaire — pas en cherchant l'équilibre parfait, mais en acceptant de faire des choix forts et des efforts concentrés sur ce qui compte vraiment, à chaque période de ta vie.

Matt Spiegel and Laurence Holmes had fun with the latest developments and details surrounding the Bears' proposed stadium site in Hammond, Ind. It doesn't sound like a good place to build a state-of-the-art stadium, to say the least.

Leila Rahimi and Marshall Harris reacted to the report that the Bears' proposed stadium in Hammond, Ind. would be built on a slag heap.

In the third hour, Leila Rahimi and Marshall Harris discussed a variety of sports topics in the 5 On It segment. After that, they reacted to the report that the Bears' proposed stadium in Hammond, Ind. would be built on a slag heap. Later, they discussed Spurs star Victor Wembanyama's amazing performance in his team's double-overtime win against the Thunder in Game 1 of the Western Conference finals Monday.

Tous les mots ne se valent pas. Certains mots vous permettent de vendre. Ce sont les mots magiques.Dans cet épisode mon invité Selim Niederhoffer nous en révèle trois et nous explique comment les utiliser pour maximiser nos résultats.Vous pouvez retrouver Sélim sur LinkedIn et acheter son livre Les Mots Magiques, c'est une pépite pour tous les créateurs de contenu.---------------Pour travailler avec moi vous pouvez :> Suivre une de mes formationsStratégie Persona : Comprenez vos clientsStratégie Emailing : Faites décoller votre base emailsStratégie Indépendante : Communiquez en ligne (liste d'attente)> Réserver une heure de conseils personnalisés> Devenir partenaire du Podcast du Marketing---------------

durée : 00:10:07 - Les émissions culturelles de France Culture - par : Marie Sorbier - Cette année encore la sélection parallèle de l'ACID du Festival de Cannes promet des films singuliers, osés et engagés. - réalisation : Laurence Malonda, Zoé Couppé - invités : Pauline Ginot Déléguée générale de l'ACID (Association du Cinéma Indépendant pour sa Diffusion) Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

Alô, alô! O desenvolvimento e popularização das canetas emagrecedoras como Ozempic e Mounjaro balançaram as redes sociais, mídias e tantos outros espaços públicos. Facilmente a gente encontra pessoas perguntando: Quanto custa? Precisa de receita? Faz mal? Qual é o preço popular? Tem genérico? E tantos outros termos. Aqui no Brasil, a importação das canetas emagrecedoras aumentou 88% em 2025, superando até mesmo o mercado de celulares! Isso sem contar o crescimento de um mercado ilegal, com casos de contrabando e falsificação desse tipo de medicamento. Mas será que tem tantas pessoas que precisam de canetas emagrecedoras assim?  E para além de pensar se “tal uso faz bem” ou se “tal uso faz mal”, será que não é preciso pensar no que leva as pessoas a essa busca excessiva pelos padrões de magreza? Quais são as consequências desse uso? O quanto as pessoas estão dispostas a sofrer para entrarem nesse padrão?  Para essa conversa, Caramelo, Marx e Jefferson chamaram a Prof.ª Fernanda Scagliusi e o Prof. Bruno Gualano que, juntos, respondem: Afinal, pra que ficar magro? E mais importante: quem tem o direito de ficar e permanecer magro? Assuntos abordados: 00:00 – Apresentação dos convidados03:30 – O que são as canetas emagrecedoras?11:24 – Quem usa canetas emagrecedoras?22:15 – Economia Moral: estigma de pessoas gordas.28:43 – Sem tempo pra emagrecer.39:22 – Medo de engordar.48:34 – Mundo Fitness: industria trilionária. Referências e links:Centro de Medicina e Estilo de Vida ARTIGOS JORNALÍSTICOS: https://jornal.usp.br/ciencias/estetica-cultura-e-classe-o-que-esta-por-tras-do-uso-de-canetas-emagrecedoras-sem-indicacao/ https://www1.folha.uol.com.br/colunas/bruno-gualano/2026/01/ozempics-acabarao-com-a-fome-do-mundo.shtml https://www1.folha.uol.com.br/colunas/bruno-gualano/2026/01/vem-a-caneta-vai-se-o-peso-vai-se-a-caneta-vem-o-peso.shtml  https://oglobo.globo.com/saude/noticia/2026/01/21/anvisa-proibe-canetas-emagrecedoras-do-paraguai-de-tirzepatida-e-retatrutida-vendidas-sem-registro.ghtml ARTIGOS CIENTÍFICOS: Scagliusi, F. B., Gualano, B., Andreassen, P., SturtzSreetharan, C., Jensen, S. D., & Brewis, A. (2025). The Uncharted Territory of the New Obesity Drugs in Users Without Obesity: A Sociomedical Perspective. Obesity. https://onlinelibrary.wiley.com/doi/10.1002/oby.70069  Scagliusi, F. B., Ulian, M. D., de Oliveira, L. C., Torres, T. H., Unsain, R. A. F., SturtzSreetharan, C., … & Brewis, A. (2025). What is the felt experience of weight stigma in Latin America and the Caribbean? A systematic narrative review. The Lancet Regional Health–Americas. https://www.sciencedirect.com/science/article/pii/S2667193X25003643  Jensen, S. D., Gualano, B., Andreassen, P., Scagliusi, F. B., SturtzSreetharan, C., & Brewis, A. (2025). Beyond the prescription: Global observations on the social implications of GLP-1 receptor agonists for weight loss. PLOS Global Public Health, 5(12), e0005516. https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0005516  VÍDEOS, LIVROS E ETC: PPG-ANS: Ciência, Café e Prosa – Aula “Estigma relacionado ao peso corporal e o cuidado em saúde” – Professora Fernanda Scagliusi https://www.youtube.com/watch?v=1HkzyrwXPDk  Bruno Gualano: “O mundo fitness é individualizante e egoísta”, Podcast da Semana – Revista Gama https://gamarevista.uol.com.br/podcast/podcast-da-semana/bruno-gualano/  Giro Saúde Especial | Indústria do Bem Estar https://www.canalsaude.fiocruz.br/audios/479 Assine pelo Apoia.se Assine pelo Patreon ➡️ Siga o Alô nas Redes:Instagram | Facebook | TikTok | Youtube | Bluesky

Become a Big Dog Member here: https://bdge.co/memberships/fantasy_football/pricing0:00 - it's rude to skip intros0:24 - bijan robinson, RB, ATL (pick #1)2:41 - jahmyr gibbs, RB, DET (pick #2)5:18 - puka nacua, WR, LAR (pick #3)5:48 - jaxon smith-njigba, WR, SEA (pick #4)7:30 - ja'marr chase, WR, CIN (pick #5)9:15 - christian mccaffrey, RB, SF (pick #6)10:50 - jonathan taylor, RB, IND (pick #7)12:18 - amon-ra st. brown, WR, DET (pick #8)12:41 - ceedee lamb, WR, DAL (pick #9)14:20 - james cook, RB, BUF (pick #10)17:19 - justin jefferson, WR, MIN (pick #11)19:54 - saquon barkley, RB, PHI (pick #12)21:20 - ashton jeanty, RB, LV (honorable mention)subscribe to the bdge dynasty channel: https://ytube.io/3pZklisten to the bdge dynasty podcast: https://bityl.co/NzJ1bdge nfl trivia youtube channel: https://ytube.io/3jmJjoin the BDGE discord: https://discord.gg/77BxrqCF6Fsubscribe to the BDGE podcast | https://linktr.ee/bdgefollow me on the socials | https://linktr.ee/nickercolanoContact▪️ business inquiries | business@bdge.co▪️ customer support/help | help@bdge.co▪️ fantasy questions can go in our discord | https://discord.gg/AvpY3QJTAythis video is about (bdge,nick ercolano,fantasypros,fantasy flock,fantasy footballers,bdge fantasy football,fantasy football mock draft,2026 fantasy football,2026 fantasy football draft,2026 fantasy football mock draft)Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Confira os destaques do Jornal da Manhã deste domingo (10): Deputados da oposição pedem o fim de “decisões monocráticas”. A movimentação ganha força após a recente suspensão da Lei da Dosimetria pelo ministro Alexandre de Moraes, ato classificado por parlamentares como uma interferência direta na soberania do Legislativo. A Frente Parlamentar do Empreendedorismo quer incluir na PEC da escala 6x1 a exclusão da competência da Justiça do Trabalho em disputas que envolvam a terceirização em ações relacionadas a contratos de serviços e parcerias. O deputado Joaquim Passarinho (PL-PA) disse que casos passariam à Justiça comum. O governo federal lança nesta semana o plano contra o crime organizado. A medida será tomada após reunião dos presidentes Luiz Inácio Lula da Silva (PT), do Brasil, e Donald Trump, dos Estados Unidos. O ex-secretário nacional de Segurança Pública, José Vicente, opina sobre o projeto e diz quais pontos precisam ser melhorados e criticou: “Governo não tem política nacional para segurança pública”. O ministro Kassio Nunes Marques assumirá oficialmente a presidência do Tribunal Superior Eleitoral nesta terça-feira (12). O magistrado, indicado ao STF por Jair Bolsonaro, sucede a Alexandre de Moraes no comando da Corte, responsável por organizar e fiscalizar o sistema eleitoral brasileiro. O vice-presidente será André Mendonça. A superintendente de desenvolvimento da Federação das Indústrias do Estado de Minas Gerais (FIEMG), Erika Morreale, defende mais tempo para debater o fim da escala 6x1. Ela fala quais os desafios da indústria caso a PEC seja aprovada. A Justiça do Rio de Janeiro decidiu manter a prisão do ex-goleiro Bruno Fernandes após nova análise de recurso da defesa. O ex-goleiro estava em liberdade condicional e precisava atender um protocolo de medidas cautelares, como comunicar à Justiça qualquer deslocamento fora do RJ e não poder sair no período noturno, o que não foi cumprido. O deputado federal Sanderson (PL-RS) classificou como "inaceitável" a suspensão da Lei da Dosimetria pelo Supremo Tribunal Federal. A suspensão paralisa a norma que alterava a redução de penas de crimes contra o Estado Democrático de Direito, especialmente os ocorridos nos atos de 8 de janeiro de 2023 até que o plenário da Corte analise o mérito da questão. Essas e outras notícias você acompanha no Jornal da Manhã. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's the second half of our big ranks reveal! Let's talk about Harris's initial ranks for wide receivers and quarterbacks for the 2026 fantasy football season. Who deserves to go in the first round at these less-scarce positions? How many trustable WR1s are there really, and how should that affect your positional draft strategy? How many QBs are truly worthy of reaching for, and how does that change in a superflex league? Let's go! The 2026 season is really finally officially launched! Guest: Cousin Josh.   NOTES: Sponsor - www.TryFum.com code HARRIS for a free gift when you buy a nicotine-free, battery-free solution to quit smoking or vaping Sponsor - www.leesa.com code HARRIS for 30% off (as of May 12) and an extra $50 discount on a great mattress Sponsor - www.BetterHelp.com/harris for 10% off your first month of online therapy where you're matched with a psychotherapist who can help Follow Cousin Josh - www.instagram.com/DetectiveFisch Follow our show on Bluesky - https://bsky.app/profile/harrisfootball.com Follow on Twitter - @HarrisFootball Become a Person of the Book - https://www.amazon.com/Christopher-Harris/e/B007V3P4KK Watch the YouTube channel - www.youtube.com/harrisfootball Harris Football Yacht Club Dictionary - https://harrisfootball.github.io/dictionary.html Join the Harris Football Subreddit - www.reddit.com/r/HarrisFootball Subscribe To the Yacht Club Premium Podcast - https://harrisfootball.supportingcast.fm/   2026 Wide Receiver Ranks: 1          Ja'Marr Chase CIN 2          Jaxon Smith-Njigba     SEA 3          Puka Nacua     LAR 4          Amon-Ra St. Brown    DET 5          CeeDee Lamb  DAL 6          Nico Collins     HOU 7          Justin Jefferson           MIN 8          Drake London ATL 9          Malik Nabers   NYG 10        A.J. Brown       PHI? 11        Chris Olave      NO 12        DeVonta Smith            PHI 13        Tee Higgins     CIN 14        Terry McLaurin           WAS 15        George Pickens           DAL 16        Zay Flowers     BAL 17        Davante Adams          LAR 18        Jameson Williams       DET 19        Tetairoa McMillan      CAR 20        Rashee Rice     KC 21        D.J. Moore      BUF 22        Rome Odunze CHI 23        Emeka Egbuka TB 24        Luther Burden CHI 25        Jaylen Waddle DEN 26        Ladd McConkey          LAC 27        Garrett Wilson NYJ 28        Christian Watson        GB 29        Alec Pierce      IND 30        Courtland Sutton        DEN 31        Carnell Tate     TEN 32        Parker Washington     JAC 33        DK Metcalf      PIT 34        Chris Godwin  TB 35        Michael Pittman         PIT 36        Michael Wilson           ARI 37        Jakobi Meyers JAC 38        Mike Evans      SF 39        Makai Lemon  PHI 40        Ricky Pearsall  SF 41        Marvin Harrison          ARI 42        Jordyn Tyson   NO 43        Brian Thomas  JAC 44        Quentin Johnston       LAC 45        Jordan Addison           MIN 46        Stefon Diggs    47        Josh Downs     IND 48        Khalil Shakir    BUF 49        Jayden Reed    GB 50        Wan'Dale Robinson    TEN 51        Jauan Jennings            52        Romeo Doubs NE 53        Jalen Coker     CAR 54        Matthew Golden        GB 55        Jayden Higgins HOU 56        Brandon Aiyuk 57        Kayshon Boutte          NE 58        Jalen McMillan            TB 59        Tory Horton    SEA 60        Isaac TeSlaa    DET 61        KC Concepcion            CLE 62        Denzel Boston CLE 63        Troy Franklin   DEN 64        Tre Tucker       LV 65        Xavier Worthy KC 66        Jerry Jeudy      CLE 67        Dontayvion Wicks       PHI 68        Rashid Shaheed          SEA 69        Tre Harris        LAC 70        Omar Cooper  NYJ 71        Antonio Williams        WAS 72        Chris Bell         MIA 73        Travis Hunter  JAC 74        Calvin Ridley   TEN 75        Jalen Nailor     LV 76        Jack Bech        LV 77        De'Zhuan Stribling      SF 78        Skyler Bell       BUF 79        Adonai Mitchell          NYJ 80        Jaylin Noel       HOU   2026 Quarterback Ranks: 1          Josh Allen        BUF 2          Lamar Jackson BAL 3          Joe Burrow      CIN 4          Drake Maye    NE 5          Matthew Stafford       LAR 6          Jayden Daniels WAS 7          Caleb Williams CHI 8          Justin Herbert LAC 9          Jalen Hurts      PHI 10        Dak Prescott   DAL 11        Trevor Lawrence         JAC 12        Jared Goff       DET 13        Patrick Mahomes        KC 14        Brock Purdy    SF 15        Bo Nix  DEN 16        Jaxson Dart     NYG 17        Jordan Love     GB 18        C.J. Stroud       HOU 19        Baker Mayfield            TB 20        Kyler Murray   MIN 21        Daniel Jones    IND 22        Tyler Shough   NO 23        Sam Darnold   SEA 24        Bryce Young    CAR 25        Malik Willis     MIA 26        Cam Ward       TEN 27        Jacoby Brissett            ARI 28        Aaron Rodgers PIT 29        Fernando Mendoza    LV 30        Geno Smith     NYJ 31        Michael Penix ATL 32        Deshaun Watson        CLE 33        Tua Tagovailoa            ATL 34        Justin Fields    KC 35        Kirk Cousins    LV 36        Jameis Winston           NYG 37        Marcus Mariota          WAS 38        Shedeur Sanders         CLE 39        Mac Jones       SF 40        Joe Flacco        CIN 41        J.J. McCarthy   MIN 42        Davis Mills       HOU 43        Riley Leonard  IND 44        Cade Klubnik   NYJ 45        Jarrett Stidham           DEN 46        Ty Simpson     LAR 47        Tanner McKee PHI 48        Carson Beck    ARI 49        Carson Wentz MIN 50        Drew Allar       PIT

Durante 2025, al menos 46 personas Indígenas fueron asesinadas en América Latina por defender la tierra, el territorio y la vida. Esto no es un hecho aislado, se trata de una crisis sistemática en contra de las personas Indígenas defensoras en el mundo. En este programa presentamos el testimonio de José Silva Duarte, líder Indígena wayuu, quien ha sido víctima de varios atentados. Puedes escuchar, descargar y compartir este programa de forma gratuita. Música de introducción: - “Burn Your Village to the Ground” de The Halluci Nation. Derechos de autor, propiedad de The Halluci Nation. Usada bajo su permiso. Música de fondo: - Música de uso libre. Voces: - José Silva Duarte, director del Movimiento Indígena Nación Wayúu, Colombia. - Sandra Suaste Ávila, integrante de la Red Nacional de Organismos Civiles de Derechos Humanos “Todos los Derechos para Todas, Todos y Todes” (Red TDT), México. - Guadalupe Pastrana, Nahua, Cultural Survival, México. Producción, guión y edición: - Guadalupe Pastrana, Nahua, Cultural Survival, México. Imagen: - Cultural Survival. Enlaces: - Firma la petición al gobierno de Colombia: https://tinyurl.com/Defenderscol - Firma la petición al gobierno de México: https://tinyurl.com/Defendersmex Esta es una producción de Radio de Derechos Indígenas. Nuestros programas son gratuitos para escuchar, descargar y difundir.

Définir son offre, c'est une étape essentielle et c'est une étape qui fait peur. Parce que sans offre le marketing ne sert à rien.J'ai demandé à la Queen de l'offre irrésistible de nous livrer ses secrets, j'ai nommé Laurine Bemer. Si vous ne connaissez pas Laurine, attendez-vous à être scotché, du haut de ses 25 ans cette fille a tout compris au marketing. Elle l'applique, et ça marche.Si vous voulez enfin savoir comme construire votre offre, vous devez écouter cet épisode.Vous pouvez suivre Laurine sur les réseaux @lameuf_enrouge et lire son livre "Faites de vos réseaux sociaux une machine à cash"---------------Pour travailler avec moi vous pouvez :> Suivre une de mes formationsStratégie Persona : Comprenez vos clientsStratégie Emailing : Faites décoller votre base emailsStratégie Indépendante : Communiquez en ligne (liste d'attente)> Réserver une heure de conseils personnalisés> Devenir partenaire du Podcast du Marketing---------------

O Paraguai se encontra em um momento de radicalização da criminalização da luta pela terra, sem alternativas para comunidades camponesas que buscam desenvolver agroecologia e formas de vida para além do modelo do agronegócio de grande escala e capital transnacional, ou de latifúndio improdutivo. Ao mesmo tempo, uma nova articulação organiza pela primeira vez camponeses e indígenas juntos no Espacio de Unidad Indígena, Campesina y Popular. Em uma iniciativa recente, também, algumas organizações buscaram reiniciar a recuperação de territórios ocupados pelo agronegócio e o narcotráfico com a tentativa de ocupação com fins de reforma agrária da fazenda Lucipar, mas a tentativa resultou em prisões e repressão dos movimentos. As terras recuperadas pelo narcotráfico pelo estado acabam em mãos do poder concentrado. O episódio bilíngue foi realizado a partir de distintos materiais de pesquisa de campo realizada por Maria Luísa Vila (PROLAM) e Salvador Schavelzon (PROLAM e UNIFESP-Osasco) em 2025. Foram visitadas algumas comunidades como Tava Guarani, acompanhamos mobilizações do movimento de mulheres camponesas em Assunção, conversamos com a Coordinadora Sin Tierra del Norte, com a Organização Camponesa do Norte (OCN), além de pesquisadores, produtores familiares, indígenas e sem terra.Entrevistas incluídas no episódio: Perla Álvarez (CONAMURI e CODEHUPY), Rosa Toledo (CONAMURI), Trinidad Ortiz (San Pedro, Coordinadora Organización de Lucha por la Tierra - OLT), Roberto Salcedo (Asociación de Productores de Mandioca, Caaguazú), Mario Rivarola (Comunidad Indígena Hugua Po'i e coordenador Articulación Nacional Indígena por una Vida Digna), Luis Rojas (Economista, Universidad Nacional de Asunción) y Aída Martínez (Asociación Productora Productora Campesina e Indígenas de Guiará - APCIG). A última entrevista é da Maria Luísa Vila, em novembro de 2025; as outras de abril e julho de 2025, feitas por Salvador Schavelzon. Produção, pesquisa, edição e apresentação: Maria Luísa Vila e Salvador Schavelzon. 

No podcast do PublishNews dessa semana, falamos sobre o Prêmio PublishNews, a única premiação dedicada a reconhecer o trabalho dos profissionais do livro, que chega na décima edição. Falamos sobre as novidades, destacando categorias, vencedores e novidades do evento. E também temos depoimentos contando um pouco das suas trajetórias e dicas das indicadas de Profissional de Marketing e Vendas do Ano: Carolina Carvalho Corazzin, gerente de marketing da Mythos Editora, Claudia Machado, gerente comercial da Catavento Distribuidora, Eliete Rente Cotrim, gerente comercial e de marketing da Editora 34, Lis Ribeiro,coordenadora de comunicação da Câmara Brasileira do Livro (CBL), Mariana Figueiredo, diretora executiva de marketing e comunicação do Grupo Companhia das Letras, Natália Alexandre da Silva, gerente de marketing das editoras Sextante e Arqueiro.Esta chegando a Décima Edição do Prêmio PublishNews, a principal celebração do mercado editorial brasileiro. Restrito a convidados, o evento chega à marca de 10 anos reconhecendo os profissionais e as iniciativas que fazem o livro acontecer no país. No dia 6 de maio, a premiação reunirá, no icônico Theatro São Pedro, em São Paulo, editores, livreiros, distribuidores, autores, jornalistas, influenciadores e outros agentes dessa indústria criativa. Ao longo da noite serão entregues 36 troféus, um recorde! Um deles vai para o fundador e CEO da Companhia das Letras, Luiz Schwarcz, pela sua trajetória e contribuição ao setor livreiro. O Prêmio PublishNews 10 anos conta com o apoio das seguintes marcas: Skeelo (patrocinador Master); Bookwire, Catavento, CBL, MVB, Radar de Licitações e Transpo (patrocinadores Ouro); Abrelivros, Estante Virtual, Nielsen BookData e SNEL (patrocinadores Prata); e LabPub, NESPE e Secretaria da Cultura, Economia e Indústria Criativas do Estado de São Paulo (que são os apoiadores). Tudo isso e muito mais, sob o comando da dupla de jornalistas e escritores Joyce Ribeiro e Marcelo Duarte. Prêmio PublishNews: uma década celebrando o mercado editorial! A Câmara Brasileira do Livro realizará, de 13 a 15 de maio de 2026, a 5ª edição do Encontro de Editores, Livreiros, Distribuidores e Gráficos — o EELDG.Serão três dias de conteúdo estratégico, networking qualificado e troca de experiências com os principais profissionais do setor editorial, no Casa Grande Hotel Resort & Spa, no Guarujá (SP).As inscrições para participação presencial ou on-line já estão abertas no Sympla, basta procurar pelo nome do evento ou acessar www.cbl.org.br. Garanta sua vaga e aproveite os descontos dos primeiros lotes.Este podcast é um oferecimento da MVB América Latina! Onde a inovação e tecnologia impulsionam o mercado do livro. Com a Pubnet, você ganha eficiência, agilidade e segurança em cada pedido.E quando o assunto é metadados… metadados é com Metabooks! Porque, no fim das contas, o propósito da MVB é um só: levar os livros até os leitores! https://pt.mvb-online.com/Já ouviu falar em POD, impressão sob demanda? Nossos parceiros da UmLivro são referência dessa tecnologia no Brasil, que permite vender primeiro e imprimir depois; reduzindo custos com estoque, armazenamento e distribuição. Com o POD da UmLivro, você disponibiliza 100% do seu catálogo sem perder nenhuma venda. http://umlivro.com.br

Angelina Sacbajá (maya kaqchikel), integrante de la Alianza Continental de Partería Indígena y Tradicional de las Américas, nos compartió, durante la sesión 25° del Foro Permanente de la ONU para las Cuestiones Indígenas, recomendaciones clave para asegurar el reconocimiento de la partería. También habló sobre los desafíos que enfrentan las parteras en el contexto actual, especialmente frente a legislaciones que aún no reconocen plenamente su labor. Puedes escuchar, descargar y compartir este programa de forma gratuita. Música de introducción: - “Burn Your Village to the Ground” de The Halluci Nation. Derechos de autor, propiedad de The Halluci Nation. Usada bajo su permiso. Música de fondo: - Música de uso libre. Voces: - Angelina Sacbajá, Alianza Continental de Partería Indígena y Tradicional de las Américas, Guatemala. - Rosy Sul González, maya kaqchikel, Cultural Survival, Guatemala. Entrevista, producción, guión y edición: - Rosy Sul González, maya kaqchikel, Cultural Survival, Guatemala. Imagen: - Cultural Survival. Esta es una producción de Radio de Derechos Indígenas. Nuestros programas son gratuitos para escuchar, descargar y difundir.

A 60 ans, le peintre Henri Rousseau, ancien commis d'octroi et flâneur en banlieue parisienne, se fait connaitre pour ses jungles aussi sauvages qu'imaginaires. Il invente un style encore inconnu, le primitivisme.Découvrez la fascinante histoire du Douanier Rousseau, ce peintre autodidacte qui a su conquérir le monde de l'art malgré les railleries de ses contemporains.

U.S. Air Force Maj. David Miller, chaplain, and Tech. Sgt. Rita Jimenez, chaplain's assistant, both assigned to the 122nd Fighter Wing, Fort Wayne, Ind., discuss the importance of airmen understanding and utilizing the support that is available to them through the chaplain's office. Miller also shares stories and experiences from his years serving as a chaplain in both the Army National Guard and the Air National Guard. (U.S. Air National Guard audio by Tech. Sgt. Kathleen LaCorte)

Rosa Fátima Mamani Quispe (aymara), en representación de la Red Chimpu Warmi de Bolivia durante la sesión 25° del Foro Permanente de la ONU para las Cuestiones Indígenas, nos concedió una entrevista en la que destacó las exigencias de las mujeres Indígenas al Estado boliviano. Puedes escuchar, descargar y compartir este programa de forma gratuita. Música de introducción: - “Burn Your Village to the Ground” de The Halluci Nation. Derechos de autor, propiedad de The Halluci Nation. Usada bajo su permiso. Música de fondo: - Música de uso libre. Voces: - Rosa Mamani, Red Chimpu Warmi, Bolivia. - Guadalupe Pastrana, Nahua, Cultural Survival, México. Entrevista, producción, guión y edición: - Guadalupe Pastrana, Nahua, Cultural Survival, México. Imagen: - Cultural Survival. Esta es una producción de Radio de Derechos Indígenas. Nuestros programas son gratuitos para escuchar, descargar y difundir.

In Dübendorf wird am Gemüse der Zukunft geforscht. Wozu braucht es das? Weitere Themen: · Restliche Aktionärsgemeinden des Spitals Wetzikon müssen nach dem Rückzieher von Bubikon noch mehr für die Sanierung bezahlen · Limeco hat Fernwärmenetz im Limmattal ausgebaut · Polizei kürzt 1.Mai-Umzugsroute in Winterthur

No podcast do PublishNews dessa semana, conversamos com duas editoras que têm chamado atenção, seja pelas filas em eventos ou quanto no que estão fazendo no mercado fora do tradicional.Conversamos com Lucas de Lucca, fundador da Editora Flyve e Elimar Souza da editora sênior da Editora Fruto Proibido. Eles compartilham suas experiências de inovação, relação com seus autores, curadoria e estratégias de mercado no setor editorial, destacando os desafios e oportunidades de publicar livros que atendem às demandas do público."Vem aí a Décima Edição do Prêmio PublishNews, a principal celebração do mercado editorial brasileiro. Restrito a convidados, o evento chega à marca de 10 anos reconhecendo os profissionais e as iniciativas que fazem o livro acontecer no país. No dia 6 de maio, a premiação reunirá, no icônico Theatro São Pedro, em São Paulo, editores, livreiros, distribuidores, autores, jornalistas, influenciadores e outros agentes dessa indústria criativa. Ao longo da noite serão entregues 36 troféus, um recorde! Um deles vai para o fundador e CEO da Companhia das Letras, Luiz Schwarcz, pela sua trajetória e contribuição ao setor livreiro. O Prêmio PublishNews 10 anos conta com o apoio das seguintes marcas: Skeelo (patrocinador Master); Bookwire, Catavento, CBL, MVB, Radar de Licitações e Transpo (patrocinadores Ouro); Abrelivros, Estante Virtual, Nielsen BookData e SNEL (patrocinadores Prata); e LabPub, NESPE e Secretaria da Cultura, Economia e Indústria Criativas do Estado de São Paulo (que são os apoiadores). Tudo isso e muito mais, sob o comando da dupla de jornalistas e escritores Joyce Ribeiro e Marcelo Duarte. Prêmio PublishNews: uma década celebrando o mercado editorial!Indicações:Filme - Devoradores de estrelas Audiolivro - Devoradores de estrelas - Andy Weir - Narrado por Rafael Maia (Suma)Filme - LalalandFilme - Cinema ParadisoFilme - Super Xuxa Contra Baixo Astral A Câmara Brasileira do Livro realizará, de 13 a 15 de maio de 2026, a 5ª edição do Encontro de Editores, Livreiros, Distribuidores e Gráficos — o EELDG.Serão três dias de conteúdo estratégico, networking qualificado e troca de experiências com os principais profissionais do setor editorial, no Casa Grande Hotel Resort & Spa, no Guarujá (SP).As inscrições para participação presencial ou on-line já estão abertas no Sympla, basta procurar pelo nome do evento ou acessar www.cbl.org.br. Garanta sua vaga e aproveite os descontos dos primeiros lotes.Este podcast é um oferecimento da MVB América Latina! Onde a inovação e tecnologia impulsionam o mercado do livro. Com a Pubnet, você ganha eficiência, agilidade e segurança em cada pedido.E quando o assunto é metadados… metadados é com Metabooks! Porque, no fim das contas, o propósito da MVB é um só: levar os livros até os leitores! https://pt.mvb-online.com/Já ouviu falar em POD, impressão sob demanda? Nossos parceiros da UmLivro são referência dessa tecnologia no Brasil, que permite vender primeiro e imprimir depois; reduzindo custos com estoque, armazenamento e distribuição. Com o POD da UmLivro, você disponibiliza 100% do seu catálogo sem perder nenhuma venda. http://umlivro.com.br

Dans cet épisode, Rebecca et moi discutons des meilleures pratiques pour optimiser les campagnes d'emailing et de marketing automation. On y aborde l'importance de l'omnicanal, de l'optimisation mobile, du ciblage et de la personnalisation, ainsi que des aspects techniques comme la délivrabilité et le support technique. Rebecca partage des conseils pratiques pour améliorer l'efficacité des campagnes et souligne l'importance de tester les solutions disponibles.Vous pouvez suivre Rebecca sur LinkedIn, en apprendre plus sur l'emailing sur la chaine Youtube d'Active Trail. ---------------Pour travailler avec moi vous pouvez :> Vous former en autonomieStratégie Persona : Comprenez vos clientsStratégie Emailing : Faites décoller votre base emailsStratégie Indépendante : Communiquez en ligne (liste d'attente)Stratégie Advocacy : Donnez les clés de LinkedIn à vos employés (à venir)> Réserver une heure de conseils personnalisés> Devenir partenaire du Podcast du Marketing---------------

Squarepusher - K5 Fremantle - WARPMedlar - Atlantean (Josh Ludlow Remix) - Delusions Of GrandeurFSQ, Moniquea, XL Middleton - Feeling Wide (Prins Thomas Diskomiks Instr.) - Soul Clap x Mofunk Phil Karn (Mutations UK) Black 80's, Fetsum, Jazzanova - Walk With Me - Sonar KollektivNew Jackson - The Night Mail - POGO RecordingsSam Goku - X-Plor09 (Much To Give) - Permanent VacationByron the Aquarius - Song For A Friend (feat. Cropper) - EgloEnaWadan - Inner Joys Of Life - Sonar KollektivMaurice Fulton - Space - TransfusionPhil Karn - Asteroid (2002) - IndépendantMad Professor - H2so4 - Ariwa

Confira os destaques do Jornal da Manhã deste sábado (25): O ministro do Supremo Tribunal Federal Alexandre de Moraes determinou a prisão do último núcleo de condenados por envolvimento na trama golpista. Entre eles está o ex-diretor da PRF (Polícia Rodoviária Federal), Silvinei Vasques, que foi condenado a 24 anos e 6 meses de prisão. Reportagem: Pedro Tritto. Os Estados Unidos aprovaram a execução por pelotão de fuzilamento em decisão do presidente Donald Trump, segundo comunicado. A medida gerou reação internacional, e o papa Leão XIV classificou a pena de morte como “inadmissível”. Reportagem: Carlos Martins. Em informação exclusiva para a Jovem Pan, o presidente do PL, Valdemar Costa Neto, afirmou que o partido deve definir o nome para a disputa ao Senado em até dez dias. Segundo ele, a decisão ficará nas mãos do deputado Eduardo Bolsonaro (PL), que deve conduzir a escolha dentro da legenda. Nos bastidores, o nome mais cotado é o de André do Prado, presidente da Alerj, embora ainda não tenha sido confirmado. Reportagem: Beatriz Manfredini. A Polícia Militar intensificou uma operação contra o roubo de celulares na capital paulista, com foco em pontos considerados críticos. A ação mobiliza mais de 200 policiais, com uso de motos, viaturas e drones, além de mirar grupos conhecidos como “gangue do quebra-vidro”. Reportagem: Julia Fermino. O estado de São Paulo reforçou o alerta para a vacinação contra doenças durante a Semana Mundial da Imunização. A campanha segue em todo o estado até o dia 30 de maio, com aplicação gratuita de vacinas pelo SUS (Sistema Único de Saúde). O deputado Paulinho da Força (Solidariedade) falou sobre o projeto de lei da dosimetria e os vetos do presidente Lula (PT) à proposta. O relator articula a retomada do debate no Congresso Nacional sobre o tema. Reportagem: Caio César. O professor de Relações Internacionais da UFPB Augusto Teixeira avaliou os possíveis desdobramentos das negociações entre Estados Unidos e Irã. Segundo ele, o cessar-fogo pode ser reforçado ou até colapsar, a depender dos próximos movimentos diplomáticos. A Superintendência de Economia da Confederação Nacional da Indústria (CNI) estima que o fim da escala 6x1 pode gerar uma perda de cerca de R$ 76,9 bilhões ao Produto Interno Bruto (PIB). Marcio Guerra, superintendente de economia da CNI, explica os dados e discute como as empresas podem reagir ao cenário. Após avanço no Congresso Nacional, a proposta que prevê o fim da escala 6x1 entra em uma nova fase de tramitação. O advogado trabalhista Rubens Gama avalia os próximos passos do projeto e destaca que é esperado haver reação do setor empresarial diante das possíveis mudanças na jornada de trabalho. O governo federal, através do Ministério do Trabalho e Emprego, criou novas regras para reduzir juros considerados abusivos no crédito consignado após dados alarmantes do endividamento das famílias. A medida prevê a definição de limites para empréstimos, com o objetivo de diminuir o custo para os consumidores. Reportagem: Matheus Dias. Essas e outras notícias você acompanha no Jornal da Manhã. Learn more about your ad choices. Visit megaphone.fm/adchoices

Indígenas de Topolobampo acudiremos a la Corte Interamericana para frenar a Mexinol: activistasEnlace para apoyar vía Patreon:https://www.patreon.com/julioastilleroEnlace para hacer donaciones vía PayPal:https://www.paypal.me/julioastilleroCuenta para hacer transferencias a cuenta BBVA a nombre de Julio Hernández López: 1539408017CLABE: 012 320 01539408017 2Tienda:https://julioastillerotienda.com/ Hosted on Acast. See acast.com/privacy for more information.

Uma instalação em grande escala que atravessa verticalmente os três andares do Pavilhão Ciccillo Matarazzo. A obra de Ana Raylander Mártis dos Anjos foi pensada a partir de fragmentos da antiga casa de pau a pique de seu bisavô, que foi demolida, mas que pela memória continua habitada. O trabalho remonta à história de Bené e seus nove filhos, uma família afro-brasileira, e suas nove colunas cruzam um dos maiores símbolos da arquitetura moderna de São Paulo. Provocador em proposta e em tamanho, a obra nos faz questionar: quem tem direito à escala monumental? Quem no Brasil pode erguer pilares e atravessar andares? Neste episódio, que combina arte e psicanálise, a artista Ana Raylander Mártis dos Anjos, a cantora Xênia França e a psicanalista Maria Homem falam sobre a dimensão histórica e política de objetos transmitidos por gerações, memória e herança familiar. O podcast é uma coprodução do UOL com a Fundação Bienal de São Paulo. Esta temporada do podcast Em obras é um projeto realizado com recursos do Fomento Cult SP – ProAC, programa do Governo do Estado de São Paulo, por meio da Secretaria da Cultura, Economia e Indústria Criativas.

Confira os destaques do Jornal da Manhã desta quinta-feira (23): Em comentário, José Maria Trindade afirmou que os principais candidatos à Presidência começaram a desenvolver as estratégias definidas por suas equipes de campanha com o objetivo de conquistar a preferência do eleitorado, marcando uma nova fase na disputa eleitoral. Em entrevista exclusiva, o senador Alessandro Vieira afirmou que não se intimida após o ministro do STF Gilmar Mendes enviar um pedido de investigação contra ele à Procuradoria-Geral da República. Vieira destacou que sua atuação faz parte do processo democrático e defendeu a criação de um código de ética para a Corte. O embate ocorre após o senador ter solicitado o indiciamento de ministros na CPI do Crime Organizado, pedido que acabou sendo rejeitado no relatório final. O Papa Leão XIV visitou nesta quarta-feira (22) uma prisão em Bata, na Guiné Equatorial, durante viagem apostólica à África, segundo o Vaticano, com o objetivo de defender a dignidade e os direitos humanos dos prisioneiros. O país é considerado um dos mais repressivos da região e é governado desde 1979 por Teodoro Obiang Nguema Mbasogo, o presidente mais antigo do mundo. O presidente do Parlamento do Irã, Mohammad Bagher Ghalibaf, descartou a reabertura do Estreito de Ormuz enquanto durar o bloqueio dos Estados Unidos aos portos iranianos. A chancelaria iraniana também evitou comentar a prorrogação do cessar-fogo anunciada por Donald Trump. A crise se intensifica no Estreito de Ormuz, rota estratégica para o comércio global de petróleo. A Guarda Revolucionária Islâmica informou ter interceptado dois navios mercantes que tentavam atravessar a região bloqueada. O ministro do Supremo Tribunal Federal, André Mendonça, autorizou nesta quarta-feira (22) que o banqueiro Daniel Vorcaro realize exames no hospital. A previsão é que o empresário, dono do Banco Master, seja levado à unidade de saúde nesta quinta-feira (23). Preso na Superintendência da Polícia Federal em Brasília, Vorcaro relatou nos últimos dias que não estava se sentindo bem, o que motivou a autorização para a realização dos exames médicos fora do local de detenção. A chamada “taxa das blusinhas” evitou a entrada de R$ 4,5 bilhões em produtos importados de pequeno valor no Brasil, segundo uma nota técnica divulgada nesta quarta-feira (22) pela CNI (Confederação Nacional da Indústria). De acordo com o levantamento, a redução das compras internacionais contribuiu para preservar 135,8 mil empregos e manter R$ 19,7 bilhões na economia brasileira. As forças armadas dos Estados Unidos interceptaram pelo menos três petroleiros com bandeira iraniana em águas asiáticas e estão redirecionando as embarcações para longe de posições próximas à Índia, Malásia e Sri Lanka, segundo fontes marítimas e de segurança ouvidas pela Reuters. A ação ocorre após Washington impor um bloqueio ao comércio marítimo do Irã, enquanto Teerã reagiu com disparos contra embarcações para dificultar a navegação pelo Estreito de Ormuz, na entrada do Golfo Pérsico. Uma operação da Polícia Civil de São Paulo prendeu nesta quinta-feira (23) dois suspeitos, entre eles um ex-gerente de banco, acusados de participar de um esquema de fraudes bancárias que desviou R$ 14 milhões de uma conta empresarial. A quadrilha atuava na habilitação irregular de credenciais corporativas, permitindo o acesso indevido às contas de clientes. Os valores eram rapidamente transferidos por TED, PIX e boletos para dificultar o rastreamento. Ao todo, foram cumpridos cinco mandados de prisão e 22 de busca e apreensão em São Paulo e no estado de Goiás. Essas e outras notícias você acompanha no Jornal da Manhã. Learn more about your ad choices. Visit megaphone.fm/adchoices

O Roda Viva desta segunda-feira (20) recebe o escritor e professor Daniel Munduruku.Doutor em Educação pela Universidade de São Paulo e pós-doutor em Linguística pela Universidade Federal de São Carlos, Munduruku é autor de mais de 70 livros e tornou-se recentemente o primeiro indígena a ocupar uma cadeira na Academia Paulista de Letras em seus 116 anos de história. Durante a entrevista, o escritor aborda a literatura como sua “forma de fazer política” e destaca que o reconhecimento acadêmico e institucional não apaga a ancestralidade; ao contrário, reforça a capacidade dos povos indígenas de ocupar diferentes espaços sem abrir mão de sua identidade. A bancada de entrevistadores será formada por Anápuàka Tupinambá, jornalista e criador da Etnomídia Indígena e da Rádio Yandê; Auá Mendes, artista visual e arte-educadora do povo Mura; Carlos Messias, escritor e jornalista; Carolina Dantas, editora da InfoAmazonia; Laís Duarte, repórter da TV Cultura; e Maria Luiza Silveira, psicóloga e jornalista especializada em questões indígenas. O programa conta ainda com a participação do cartunista Eduardo Baptistão.

Neste episódio especial do Fronteiras no Tempo, recebemos o Cacique Japoteru Pataxó para compartilhar histórias de seu povo e dos povos indígenas do Brasil. Em abril, mês de celebrações e reflexões, discutimos a importância das tradições, saberes e visões de mundo indígenas, fundamentais para compreender nossa história e construir um futuro mais justo. O episódio aborda a luta por direitos, a reparação histórica e o protagonismo indígena na sociedade brasileira. Uma conversa potente e necessária, que convida todos nós a reconhecer e apoiar essa causa pela vida e liberdade dos povos originários. Awêry (Obrigado)! Arte da Capa Artes do Episódio: C. A. Financiamento Coletivo Existem duas formas de nos apoiar Pix recorrente – chave: fronteirasnotempo@gmail.com Apoia-se – https://apoia.se/fronteirasnotempo Episódios Relacionados e Recomendados Fronteiras no Tempo Fronteiras no Tempo #35: Indígenas na História do Brasil Fronteiras no Tempo #63 As funções dos guerreiros na cultura Tupi Guarani Fronteiras no Tempo #75 Questão indígena na história do Brasil Fronteiras no Tempo: Giro Histórico Fronteiras no Tempo: Giro Histórico #45 História Indígena, mitos e lendas de Roraima Fronteiras no Tempo: Historicidade Fronteiras no Tempo: Historicidade #57 A queda do céu: escrita e história indígenas Fronteiras no Tempo: apresenta Fronteiras no Tempo apresenta: Isso é História de Guarapuavano #2 Etnias Indígenas de Guarapuava Spin de Notícia História indígena: sobre o que estamos falando? – 9 Borean (Spin#1908 – 07/02/2023) O significado dos Indígenas na História do Brasil – 21 Driadan (Spin#1618 – 16/04/2022) Chutando a Escada Chute 237 – Genocídio indígena no Brasil Como citar esse episódio Fronteiras no Tempo #97 Histórias Indígenas. Locução Marcelo de Souza Silva, Cacique Japoteru Pataxó, Cesar Agenor Fernandes da Silva e Willian Spengler [S.l.] Portal Deviante, 21/04/2026. Podcast. Disponível em: https://www.deviante.com.br/?p=66849&preview=true Expediente Produção Geral: C. A. e Beraba. Host: Marcelo Beraba. Convidado Especial: Cacique Japoteru Pataxó. Recordar é viver: Willian Spengler. Artes do Episódio: C. A. Edição: Talk’nCast Redes Sociais Facebook, Youtube, Instagram Contato fronteirasnotempo@gmail.com Madrinhas e Padrinhos Apoios a partir de 12 de junho de 2024 Alexsandro de Souza Junior, Aline Silva Lima, André Santos, André Trapani, Andréa Gomes da Silva, Andressa Marcelino Cardoso, Augusto Carvalho, Carolina Pereira Lyon, Charles Calisto Souza, Edimilson Borges, Elisnei Menezes de Oliveira, Erick Marlon Fernandes da Silva, Flávio Henrique Dias Saldanha, Gislaine Colman, Iara Grisi, João Ariedi, Klaus Henrique de Oliveira, Manuel Macias, Marlon Fernandes da Silva, Pedro Júnior Coelho da Silva Nunes, Rafael Henrique Silva, Raul Sousa Silva Junior, Renata de Souza Silva, Ricardo Orosco, Rodrigo Mello Campos, Rubens Lima e Willian SpenglerSee omnystudio.com/listener for privacy information.

Mon invitée sait exactement comment fonctionnent les médias, donc préparez vous à prendre des notes, parce qu'aujourd'hui on rentre dans le dur : Quand faut-il communiquer auprès de la presse, avec quels outils, comment identifier les bons journalistes, et comment les démarcher, quelles sont les règles de communication, comment se préparer à une interview, et comment s'assurer qu'on a dit tout ce qu'il fallait dire. Bref, on vous détaille toute la stratégie de relation presse, je vous propose d'accueillir tout de suite Clara Armand Delille.Autres épisodes qui pourraient vous plaire :Comment construire une stratégie RP avec Delphine MargotComment construire un communiqué de presse---------------Pour travailler avec moi vous pouvez :> Choisir une formationStratégie Persona : Comprenez vos clientsStratégie Emailing : Faites décoller votre base emailsStratégie Indépendante : Communiquez en ligne (liste d'attente)Stratégie Advocacy : Donnez les clés de LinkedIn à vos employés (à venir)> Réserver une heure de conseils personnalisés> Devenir partenaire du Podcast du Marketing---------------

Confira os destaques do Jornal da Manhã deste sábado (18): Morre Oscar Schmidt, o “Mão Santa”, lenda do basquete brasileiro. Ele ganhou reconhecimento internacional ao longo da carreira, participando de cinco Olimpíadas e sendo homenageado no principal Hall da Fama do basquete mundial. Em 2017, a NBA também celebrou o brasileiro ao convidá-lo para o All-Star Game, onde recebeu uma camisa número 14 do Brooklyn Nets e entrou em quadra por alguns minutos. Selecionado pelo então New Jersey Nets em 1984, Oscar optou por não jogar na liga para seguir defendendo a seleção brasileira, já que, na época, atletas da NBA não podiam atuar por seus países. O ministro Gilmar Mendes, do Supremo Tribunal Federal (STF), restabeleceu nesta sexta-feira (17) a prisão preventiva de Monique Medeiros, acusada pela morte do filho Henry Borel em 2021. Segundo o ministro, a decisão da Justiça do Rio de Janeiro que havia concedido liberdade à ré violou entendimento da Segunda Turma do STF, destacando a necessidade da prisão para garantir a ordem pública e a instrução do processo, diante da gravidade do caso e do histórico de coação de testemunhas. Gilmar afirmou que a soltura às vésperas de depoimentos sensíveis representava risco à busca da verdade. Em nota, a defesa disse ter recebido a decisão com surpresa, afirmou que já questionou a ordem e argumentou que a privação de liberdade compromete o direito de defesa. O Irã anunciou o fechamento do Estreito de Ormuz em resposta ao que classifica como bloqueio naval mantido pelos Estados Unidos, colocando em risco cerca de 20% do petróleo mundial que passa pela rota entre o Golfo Pérsico e o Golfo de Omã. O chefe da Comissão de Segurança Nacional do Parlamento iraniano, Ebrahim Azizi, afirmou que o país havia feito alertas anteriores, enquanto o porta-voz do Quartel-General de Khatam al-Anbiya, Ebrahim Zolfaghari, declarou que Teerã havia permitido trânsito limitado de petroleiros após negociações com Washington. Segundo autoridades iranianas, os Estados Unidos descumpriram os termos e mantiveram restrições ao comércio marítimo do país. O mestre em gestão pública Marco Vinholi concedeu entrevista à Jovem Pan e analisou os impactos do projeto de lei que pode causar o fim da escala 6x1. O especialista fez uma análise sobre uma possível aprovação. O deputado federal Altineu Côrtes (PL-RJ) concedeu entrevista ao Jornal da Manhã e falou sobre o que esperar do PL da Dosimetria, detalhando os próximos passos e o impacto da proposta em discussão no Congresso Nacional. O presidente dos Estados Unidos, Donald Trump, afirmou que uma possível ação militar contra Cuba “depende da definição”, ao ser questionado antes de viajar para seu resort em Mar-a-Lago. A declaração foi dada após relatos de que o Departamento de Defesa estaria se preparando para uma eventual operação. Trump também mencionou que o país pode direcionar atenção à ilha após o processo envolvendo o Irã, criticou a situação em Cuba e classificou o país como um Estado em colapso, além de citar episódios de maus-tratos a americanos de ascendência cubana. O estado do Rio de Janeiro acumulou perdas de aproximadamente R$ 90 bilhões em receitas ligadas à indústria do petróleo apenas em 2025, segundo análises da Federação das Indústrias do Estado do Rio de Janeiro (Firjan) divulgadas em abril de 2026. Para discutir o tema, a Jovem Pan entrevista Karine Fragoso, gerente geral de Petróleo, Gás, Energias e Naval da Firjan, que detalha os impactos desse cenário na economia estadual. Essas e outras notícias você acompanha no Jornal da Manhã. Learn more about your ad choices. Visit megaphone.fm/adchoices

Indígenas de la Huasteca Potosina fijan postura tajante contra el frackingEnlace para apoyar vía Patreon:https://www.patreon.com/julioastilleroEnlace para hacer donaciones vía PayPal:https://www.paypal.me/julioastilleroCuenta para hacer transferencias a cuenta BBVA a nombre de Julio Hernández López: 1539408017CLABE: 012 320 01539408017 2Tienda:https://julioastillerotienda.com/ Hosted on Acast. See acast.com/privacy for more information.

Nesse episódio, Bruno Carvalho, Edu Aurrai, Felipe Mesquita e Rodrigo Cunha falam sobre a situação atual da Indústria dos Video Games; a mais recente leva de demissões em massa que atingiu a Eidos; o aumento de preço de todos os modelos do Playstation 5; o ajuste de preços dos jogos digitais da Nintendo no Brasil; e muito mais. Duração: 128 min Comentados: Mod de VHS do Cyberpunk 2077 COMPRE O MARS 2120, METROIDVANIA BRASILEIRO: PC (STEAM) PLAYSTATION 4, PLAYSTATION 5 XBOX ONE, XBOX SERIES S|X NINTENDO SWITCH Vídeos: Mortal Kombat II | Tickets On Sale Truxton Extreme – Release Date Trailer RPG MAKER – New Project Teaser Trailer [Português – PT] Xbox Partner Preview | Março de 2026

¡Hola a todos! Nuevo episodio en español. En este episodio exploramos la resistencia de los pueblos indígenas del sur de México frente al megaproyecto del Tren Maya. A través de casos concretos en Chiapas y Campeche, analizamos cómo comunidades ch'oles, tzeltales y tsotsiles han respondido a la deforestación, la minería extractivista y la falta de consulta en megaproyectos que impactan directamente sus territorios.Aunque el Tren Maya se presenta como una oportunidad para el crecimiento económico y el turismo, muchas comunidades denuncian sus consecuencias ambientales y sociales: pérdida de biodiversidad, desplazamiento y violación de derechos colectivos.Este episodio combina narración, contexto histórico y análisis crítico para cuestionar una idea clave:¿Puede existir el desarrollo si no incluye a quienes viven en esos territorios?Bibliografía: Best Café Molido. (s.f.). Producción de café orgánico en Chiapas.https://www.bestcafemolido.com/produccion-de-cafe-organico-en-chiapasInstituto Nacional de los Pueblos Indígenas (INPI). (s.f.). Choles: etnografía.https://atlas.inpi.gob.mx/choles-etnografia-2/Desinformémonos. (2023). Más de 12 mil indígenas en Chiapas respaldan lucha jurídica de Xpujil contra Tren Maya.https://desinformemonos.org/mas-de-12-mil-indigenas-en-chiapas-respaldan-lucha-juridica-de-xpujil-contra-tren-maya/SinEmbargo. (2019). Indígenas protestan en Chiapas contra el Tren Maya; acusan represión.https://www.sinembargo.mx/3632147/indigenas-protestan-en-chiapas-contra-el-tren-maya-con-amlo-vemos-represion-acusan-fotos/Gobierno de México. (s.f.). Tren Maya: Documento informativo.https://www.gob.mx/cms/uploads/attachment/file/513996/TM_D_ptico_GO_WEB.pdfAgua y Vida. (2021). Megaproyectos, extractivismos y conflictos socioambientales en Chiapas.https://aguayvida.org.mx/wp-content/uploads/2021/02/Documento-Megaproyectos-Extractivismos-y-Conflictos-SocioAmbientales-Chiapas.pdfSOUNDS666HeroHero. (s.f.). Wind [Efecto de sonido]. Pixabay.https://pixabay.com/sound-effects/storegraphic. (s.f.). Birds [Efecto de sonido]. Pixabay.https://pixabay.com/sound-effects/floraphonic. (s.f.). Flute [Efecto de sonido]. Pixabay.https://pixabay.com/freesound_community. (s.f.). Wind in trees [Efecto de sonido]. Pixabay.https://pixabay.com/sound-effects/freesound_community. (s.f.). Drill [Efecto de sonido]. Pixabay.https://pixabay.com/

In Düsseldorf ist Ende für Anfang und Anfang für Ende, in Berlin fängt bei Union nun die erste Trainerin der Bundesliga-Geschichte an. Was erwartet Marie-Louise Eta? Und woran ist Steffen Baumgart gescheitert? Außerdem Thema: Der Torrekord der Bayern, die Pfiffe in Dortmund gegen Nico Schlotterbeck, die schlimmen Leistungen von St. Pauli, Hamburg oder Bremen. Und fährt Matthias Ginter zur WM? Hört rein!

Le projet SIRIUS est une série de simulations internationales (impliquant notamment la NASA et l'agence russe Roscosmos) réalisées dans un complexe terrestre à Moscou. L'objectif est d'étudier les effets psychologiques et physiologiques d'un isolement prolongé sur un équipage mixte, afin de préparer les futures missions habitées vers Mars (horizon 2040).L'autonomie et la "rébellion" de l'équipage L'étude publiée dans Frontiers in Physiology met en évidence un phénomène fascinant appelé le "phénomène de détachement".Indépendance croissante : Au fil de la mission (notamment durant la simulation de 4 mois), l'équipage a tendance à s'isoler psychologiquement du centre de contrôle terrestre (MCC).Réduction de la communication : Les chercheurs ont observé une baisse significative du partage d'informations avec la Terre. L'équipage commence à prendre ses propres décisions et à moins solliciter l'avis des experts au sol, sauf lors d'étapes critiques comme l'atterrissage simulé.Solidarité interne : À mesure que les liens avec la Terre se distendent, la cohésion interne du groupe se renforce. L'équipage finit par former une "entité souveraine", moins encline à obéir aveuglément aux ordres extérieurs.Différences de comportement selon le genre L'article de Sciencepost et l'étude scientifique soulignent des nuances comportementales :Les femmes de l'équipage ont tendance à exprimer davantage de sentiments de joie et de tristesse par la communication verbale.Les hommes ont montré, dans certaines phases, des niveaux de colère plus fréquents.Cependant, sur le long terme, les profils de communication des deux sexes convergent vers une forme de régulation émotionnelle commune au groupe.Risques pour les missions réelles Cette autonomie, bien qu'essentielle pour la survie en cas de perte de signal (le délai de communication entre la Terre et Mars peut atteindre 20 minutes), inquiète les psychologues spatiaux :Le risque de déconnexion : Si l'équipage cesse de rapporter des problèmes ou de suivre les protocoles de sécurité par excès de confiance ou par sentiment d'autosuffisance, la mission pourrait être compromise.Gestion du stress : L'isolement extrême et la monotonie poussent l'équipage à créer sa propre "bulle sociale", ce qui peut masquer des tensions internes ou des défaillances psychologiques aux yeux du centre de contrôle.Le succès d'un voyage vers Mars ne dépendra pas seulement de la technologie, mais de la capacité humaine à gérer l'autonomie radicale. Le projet SIRIUS démontre que les futurs astronautes ne seront pas de simples exécutants, mais des explorateurs qui, par la force des choses, devront s'affranchir de la tutelle terrestre, avec tous les risques de rupture psychologique que cela comporte. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Confira os destaques de Os Pingos nos Is desta terça-feira (07):O jornal britânico Financial Times afirmou que a família Bolsonaro estava politicamente enfraquecida, mas que a pré-candidatura de Flávio Bolsonaro (PL-RJ) à Presidência pode ter mudado esse cenário. Segundo a reportagem, o senador recupera espaço político e surge como um nome competitivo para a disputa eleitoral. Uma decisão da Justiça dos Estados Unidos pode acelerar o acordo de delação do banqueiro Daniel Vorcaro. O Tribunal de Falências do Distrito Sul da Flórida autorizou a ampliação das investigações para identificar ativos ligados ao empresário fora do Brasil. A medida busca localizar bens que possam ter sido ocultados e reavaliar movimentações financeiras envolvendo Vorcaro ou empresas associadas a ele. O ex-governador de Minas Gerais e pré-candidato à Presidência, Romeu Zema (Novo), afirmou que não recebeu convite para ser vice na chapa de Flávio Bolsonaro (PL-RJ). Em nota, Zema disse que manterá sua candidatura até o fim do primeiro turno e destacou que a direita deve se unir apenas na etapa final da disputa contra o presidente Lula (PT). Um estudo da Confederação Nacional da Indústria (CNI) aponta que a redução da jornada de trabalho de 44 para 40 horas semanais, com a adoção da escala 5x2 sem redução salarial, pode gerar um impacto de até R$ 77 bilhões na economia brasileira. Segundo a entidade, os setores da indústria, comércio e serviços seriam os mais afetados pela mudança. A tensão no Oriente Médio aumentou após o presidente dos Estados Unidos, Donald Trump, dar um ultimato ao Irã para aceitar um acordo e reabrir o Estreito de Ormuz. Segundo autoridades americanas, o prazo termina às 21h no horário de Brasília. Caso o acordo não seja aceito, os Estados Unidos podem intensificar ataques contra alvos iranianos. O presidente dos Estados Unidos, Donald Trump, anunciou a suspensão dos bombardeios contra o Irã em meio à escalada de tensões no Oriente Médio. A decisão ocorre após dias de ameaças e troca de declarações entre os dois países, que elevaram o risco de um conflito maior na região. Você confere essas e outras notícias em Os Pingos nos Is.

This Biotech CEO Created The RedTail Platform To Fight Cancer. Guest:Eric PomaCEO of Calidi Bio CLDI Company Name:Calidi BiotherapeuticsWebsite: https://www.calidibio.com/Ticker: NYSE: CLDIEric's Bio:Eric Poma, Ph.D. has served as Chief Executive Officer and board director of Calidi since April 2025 and brings more than 30 years of experience in the biopharmaceutical industry, with a strong record of capital fundraising, big pharma collaboration agreements, and clinical program development.Prior to joining Calidi, Dr. Poma served as CEO of Molecular Templates (NASDAQ: MTEM), a clinical-stage biotech focused on the development of a novel class of therapeutic agents with unique biology in oncology. At Molecular Templates he raised over $250 million in equity financing and secured over $150 million in strategic capital through agreements with Takeda, Vertex and BMS. He previously served as Vice President, Business Development of Innovive Pharmaceuticals. Prior to that he held various senior level positions at Imclone Systems, Inc., primarily in business development. Earlier, Dr. Poma served as a Healthcare & Biotechnology Analyst with the healthcare fund Eagle Growth Investors, LLC.Dr. Poma received a Ph.D. in Microbiology and Immunology from the University of North Carolina at Chapel Hill, an M.B.A. from the Leonard N. Stern School of Business and a Bachelor of Science in Biology from the University of North Carolina at Chapel Hill.Company Bio:Calidi Biotherapeutics is a biotechnology company pioneering the development of targeted genetic medicines for cancer and other diseases through its RedTail platform. The company's lead compound, CLD-401, is a systemically delivered oncolytic virus that expresses high levels of IL-15 superagonist only in the tumor microenvironment. The company expects to file an IND to initiate clinical studies for CLD-401 by the end of 2026. The company continues to advance what the RedTail platform can achieve and will be presenting additional data throughout the year.

Confira os destaques de Os Pingos nos Is desta quinta-feira (02):Uma pesquisa da AtlasIntel e da Arko Advice apontou os políticos com maior rejeição entre os eleitores. O presidente Lula (PT) aparece em primeiro lugar no levantamento, seguido por Flávio Bolsonaro (PL-RJ) e pelo ex-presidente Jair Bolsonaro (PL). O estudo também investigou os principais motivos apontados pelos entrevistados para a rejeição aos nomes citados. O vice-presidente Geraldo Alckmin (PSB) deixou o comando do Ministério do Desenvolvimento, Indústria, Comércio e Serviços para cumprir a regra de desincompatibilização eleitoral. Confirmado como pré-candidato à vice-presidência na chapa do presidente Lula (PT), Alckmin agora deve se dedicar à campanha e às atividades na vice-presidência. O governo ainda avalia quem será o seu substituto na pasta.Alckmin afirmou que quem defende ditadura não deveria disputar eleições no Brasil. A declaração foi feita durante um café da manhã com jornalistas, em que o ministro se despediu do comando do Ministério do Desenvolvimento, Indústria, Comércio e Serviços para cumprir a regra de desincompatibilização eleitoral. O presidente Lula (PT) afirmou que o Brasil não mudará o sistema de pagamentos Pix, mesmo após críticas feitas em um relatório dos Estados Unidos. Durante visita a obras do VLT em Salvador, o presidente disse que o Pix pertence ao Brasil e destacou a importância do sistema para a população e para o funcionamento da economia. Durante um evento em Fortaleza, o presidente Lula (PT) chamou atenção ao cometer um possível ato falho ao se dirigir a jovens presentes na cerimônia. Em um trecho do discurso, o petista afirmou que os jovens seriam “honestos” e que queriam que ele também fosse. A declaração gerou repercussão e abriu espaço para críticas de opositores. O presidente do PL, Valdemar da Costa Neto, afirmou que o governador de Goiás, Ronaldo Caiado (PSD), seria um bom nome para vice na chapa de Flávio Bolsonaro (PL-RJ). No entanto, segundo apuração do jornalista Misael Mainete, Caiado não pretende aceitar o convite e mantém a pré-candidatura à Presidência da República. Outros nomes, como Tereza Cristina (PP-MS) e Romeu Zema (Novo-MG), também são citados como possíveis opções para compor a chapa. A Polícia Militar de São Paulo concedeu a aposentadoria ao tenente-coronel Geraldo Leite Rosa Neto, que está preso preventivamente e responde por feminicídio e fraude processual. A decisão foi publicada em portaria que o coloca na reserva da corporação, garantindo vencimentos integrais de cerca de R$ 20 mil mensais. O caso ganhou repercussão após a morte da policial militar Giselle Alves Santana, encontrada sem vida no apartamento onde o casal morava.Você confere essas e outras notícias em Os Pingos nos Is.

Le Contrat à Durée Indéterminée existe aussi en dehors du monde du travail. Notre Leader Bienaimé Président-Fondateur, béni soit son génie, vient d'appliquer ce concept révolutionnaire à la politique gondwanaise au niveau local... Place au mandat CDI. 

-40% : offre de lancement exclusive sur notre nouvelle formation GDIY x EDHEC "Performance Intégrale". Toutes les infos sur https://www.gdiy.fr/performance.Dans la tête des gens, la grande distribution est le capitalisme triomphant.Pourtant, c'est ce que l'on appelle un business de centimiers.Sur 100€ dépensés dans un Super U, il reste 2€ au commerçant.Dominique Schelcher a grandi entre les rayons du Super U familial de Fessenheim. À 15 ans, il jure qu'il ne fera jamais ce métier.Il part faire ses études, travaille dans la presse.Puis il revient.Il reprend le magasin de ses parents, et ne le lâchera plus.En 2018, il succède à Serge Papin à la tête de la Coopérative U, le 4ème acteur de la grande distribution française : 35 milliards de chiffre d'affaires en 2025, 1200 patrons indépendants, 1900 magasins.Le vendredi et le samedi, il est encore dans son supermarché de Fessenheim.Dans cet épisode, Dominique dévoile les coulisses d'un secteur qu'on croit connaître et qu'on comprend mal :Pourquoi la grande distribution française se décommercialiseComment fonctionne vraiment une négo et qui gagneMythes et réalité des centrales d'achatCe que coûte vraiment un Super U à ouvrir, et combien de temps pour le rentabiliserPourquoi Coopérative U cartonne là où Auchan et Casino s'effondrentLes vraies tendances de consommation que personne ne voit depuis ParisUn épisode rare avec un patron discret, ancré dans le terrain, qui parle vrai sur un secteur au cœur de la vie des Français.Vous pouvez contacter Dominique sur LinkedIn.TIMELINE:00:00:00 : Les deux modèles de la grande distribution00:14:03 : Indépendamment ensemble, le paradoxe de la coopérative00:21:08 : Pourquoi la France ferme ses magasins ?00:31:24 : La vraie marge d'un supermarché00:39:06 : L'artisanat sauve les centres-villes00:48:04 : Les crises réinventent la grande distribution00:56:48 : Les opportunités dans l'alimentation de demain01:05:02 : Combien coûte un Super U ?01:15:15 : Le scandale de Fessenheim01:23:17 : Le secret d'un bon commerçant01:33:05 : La révolution silencieuse des entrepôts français01:39:43 : Pourquoi le système de négociation français est unique au monde ?01:46:39 : U s'installe en Afrique01:55:46 : Offrir le choix aux consommateurs02:04:11 : Survivre en négo face aux géants02:12:44 : La loi qui devait protéger les agriculteurs02:21:34 : Utiliser le stoïcisme comme outil de managementLes anciens épisodes de GDIY mentionnés : #524 - Vincent Clerc - XV de France, McDonald's - L'incroyable destin d'un Grenoblois besogneux#513 - VO - Jesper Brodin - IKEA - 40 billion in revenue empire with no bank loan#513 - VF - Jesper Brodin - IKEA - 40 milliards de revenus sans jamais avoir emprunté#398 - Thierry Cotillard - Les Mousquetaires - Masterclass de la grande distribution en 2024#380 - Paul Lê - La Belle Vie - Le Son Gokû de la FoodTech qui rachète Frichti#371 - Nicolas Bouzou - Asterès - L'économie de la peur#127 - Paul Lê - La Belle Vie - De la résilience, de l'honnêteté et du travail pour réussir big timeNous avons parlé de :Les zones commerciales FreyLe café où l'on tisse des liensLa crise des « gilets jaunes » en dix datesGuerre en Ukraine : des supermarchés rencontrent des difficultés à s'approvisionnerWine ParisNotre documentaire sur la Chine : Comment la Chine est devenue imbattable ?La chaîne de magasins Grand Frais, qui passe sous pavillon américain, prévoit plus de 3 000 embauchesFessenheim: François Hollande ne regrette pas la fermeture des "deux réacteurs vieillissants"Fessenheim : un crapaud bloque l'installation de dizaines d'entreprisesQu'est-ce que Bleu-Blanc-Cœur ?La Belle VieLoi EGalimFleurons, notre nouveau podcastLes recommandations de lecture :Le bonheur est dans l'action, par Dominique SchelcherJournal, par Jean-René HugueninLe bonheur est dans le près, par Dominique SchelcherUn grand MERCI à nos sponsors : Squarespace : https://squarespace.com/doitQonto: https://qonto.com/r/2i7tk9 Brevo: brevo.com/doit eToro: https://bit.ly/3GTSh0k Payfit: payfit.com Club Med : clubmed.frCuure : https://cuure.com/product-onely (code DOIT)Vous souhaitez sponsoriser Génération Do It Yourself ou nous proposer un partenariat ?Contactez mon label Orso Media via ce formulaire.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Deb (00:03.606)Within the next seven months, up to 1.5 million Americans could lose access to a medication that they’ve relied on for decades. Not because it’s dangerous, but because a pharmaceutical giant may have lobbied the FDA to eliminate their competition. And if you’re one of them, your doctor may already have told you about this issue and stopped prescribing it.This isn’t a conspiracy theory. This is documented in federal court filings. This is happening right now. And the company that stands to profit, well, they’re the same ones manufacturing the only product that might survive.Today on Let’s Talk Wellness Now, we’re exposing the desiccated thyroid extract crisis, the corporate manipulation behind it, and what you need to do right now to protect your health. Stay with me because I’m about to share what could save your access to the medication keeping you alive.Welcome back to Let’s Talk Wellness Now, the show where we uncover the root causes of chronic illness, expose regulatory capture in healthcare, and empower you with the tools to advocate for yourself. I’m Dr. Deb, naturopathic doctor, your medical detective, and today we’re diving into one of the most consequential and corrupt healthcare decisions affecting patients right now. If you or someone you love takes Armour thyroid, NP thyroid, or any desiccated thyroid extract,for hypothyroidism or if you’ve struggled to find a thyroid medication that actually works for your body, this episode is absolutely critical. And if you have celiac disease, gluten sensitivity or corn allergies, what I’m about to reveal will make your blood boil. Now grab your cup of coffee, don’t forget your notebook and settle in because what’s happening to this medication right now is a masterclass in how pharmaceutical companies use regular Deb (02:06.544)agencies to eliminate competition, control markets, and price gouge patients. And I have all the receipts. Deb (02:20.982)Let me start with what might surprise you. Desiccated thyroid extract, or DTE as we call it, is actually one of the most oldest thyroid medications in the world. And I mean old. From the 1890s through 1970, this was the standard treatment for hypothyroidism.Now let’s really dive into that. From the 1890s to the 1970s, this was standard hypothyroidism treatment.In 1965 alone, and this is documented in peer-reviewed literature published in the Journal of Clinical Endocrinology and Metabolism, approximately four out of every five prescriptions for thyroid hormone in the United States were of natural desiccated thyroid preparations.The Journal of Clinical Endocrinology and Metabolism is a very high-end journal. Now think about that. This wasn’t some fringe therapy. This was mainstream medicine. Armour Thyroid, the most recognizable brand name, has been manufactured since the early 1900s, well over a century ago.and this is cited again in NIH bookshelf. When the FDA was officially established in 1938, Arbor thyroid was already on the market. And this is important and I want you to understand why. Under the federal Food, Drug and Cosmetic Act, any drug that was already being marketed before 1938 was automatically grandfathered into the system. That means it didn’t have to Deb (04:08.112)go through the formal FDA approval process. And this again is cited under the Federal Food, Drug and Cosmetic Act, grandfathered drugs and exemptions. And this is crucial to understanding what happens next. By the 1970s, synthetic levothyroxine, brand name Synthroid and generics became the preferred treatment. Hmm, wonder why?It was easier to standardize, came into consistent doses, and worked well for most patients, and could be mass manufactured. By the 1980s, levothyroxine had largely replaced desiccated thyroid in clinical practice, according to the American Thyroid Association 2014 guidelines for the treatment of hypothyroidism. But here’s what matters. Some patients…a very significant minority of them, never felt right on levothyroxine alone. Despite their lab work looking normal, they still had fatigue, brain fog, weight gain, cold intolerance, and depression.These patients often found relief when they switched back to their desiccated thyroid, which contains both T4 and T3 hormones, the way human thyroid naturally produces them. And this is not anecdotal. This is documented in randomized double-blind crossover studies published in Endocrine Practice.For decades, that was fine. Their doctors prescribed it, insurance sometimes covered it, patients were getting better, and the system worked really well. Until August 6th of 2025, just a short time ago, everything changed. On that date, the FDA sent letters to manufacturers, importers, and distributors of desiccated thyroid extract products stating that these medications would need an approval. Deb (06:04.654)a biologics licensed application, a BLA, to remain legally on the market. And this is cited in the FDA’s official statement, FDA’s actions to address unapproved thyroid medications. understand it says unapproved thyroid medications. However, desiccated thyroid, specifically Armour, has been approved since 1938. And this was dated August 6th through 7th, 2025.This wasn’t a guideline. This wasn’t a suggestion. It was an endorsement of action. And the timeline they gave them? Well, just 12 months to transition patients to another medication before enforcement action could begin.This was also cited by an FDA notice to the industry, animal derived thyroid products notice to industry, August 6th, 2025. Now do the math, that means August 2026, seven months from now, 1.5 million Americans currently taking this medication. And this number comes from the FDA official statement, citing that it’s an estimation of 1.5 million patients receiving prescriptions for these medications.could potentially lose their thyroid access. Now, here’s where it gets interesting. The FDA didn’t wake up in August of 2025 and decide to regulate desiccated thyroid after a century. This decision has a much longer backstory. And understanding that backstory is critical to understanding what’s really happening in this industry.The shift started in 2022. Back in September of 2022, over three years ago, an FDA branch chief sent a letter to the National Associations of Boards of Pharmacy noting that the agency had decided to designate DTE as a biological product, which would affect its eligibility for compounding. Deb (08:13.972)This also is cited in an FDA letter to the National Association of Boards of Pharmacy September 2022.Then two months later, in November of 2022, the FDA’s Office of Compounding Quality and Compliance sent a softer letter acknowledging that many Americans take medication to treat hypothyroidism and some choose to take DTE products. The letter stated that the FDA would focus enforcement on cases that pose the greatest public health risks, such as serious adverse offense or serious product quality or adulteration.also is cited by an FDA letter from Francis G. Bromel, the director, Office of Compounding Quality and Compliance, November of 2022. Now, let me just think about this for a second. If this drug has been on the market since the 1800s, been FDA approved since 1938, would we not have seen a health crisis long before 2022?I honestly don’t know of any other drug that’s been around this long that’s used by this many people. Now granted, I haven’t done the research on it either, which I can do for you guys, but I’m just thinking if a drug is on the market today and it causes harm, it doesn’t make it three years, five years before you see lawsuits everywhere. Why are there no lawsuits on this drug? Why are there no major reactions that people are seen having?Hmm, just thought. But here’s the pattern. The FDA was already laying the groundwork back in 2022, testing the waters, signaling where this was headed. The August 2025 action. Then this came down. Deb (10:09.806)August 6, 2025, the FDA announced its position publicly and sent formal letters to all DTE manufacturers, importers, and distributors. This was cited by the FDA Enforcement Action August 6, 2025, letters to manufacturers, importers, distributions of DTE products. The agency stated several concerns. First, DTE products have experienced quality and dosing issues.The FDA cited, and I’m quoting directly from their statement, over 500 adverse events reported associated with DTE products from 1968 to 2025. From 1968 to 2025, we had 500 adverse reactions? What is that math equate to?A couple a year? Come on guys, this is insane! With a substantial increase, you, between 2019 and 2020 that the agency suggested was related to voluntary recalls of sub-potent or super-potent products.This was cited in the FDA statement, over 500 adverse events reported associated with ADT products from 1968 through 2025.Second, the agency expressed concern about batch inconsistency. According to the FDA’s official statements, tablets made from the same manufacturing batches may not always provide the same thyroid hormone levels. Okay, this was cited in the FDA statement, tablets made from the same manufacturing batches may not always provide the same thyroid hormone levels. Thirdly, and I want to actually let’s back up. I want you to remember I said that Deb (12:11.216)because further down in this podcast, we’re going to talk about this. This is an important point to remember. Thirdly, the agency raised concerns about potential impurities from animal source material, including potential for viral contamination due to the animal source and supraphysiological levels of T3.the FDA statement on impurities, viral contamination and super physiological T3 levels. Now I will tell you, I’ve been prescribing armarithograde for 20 years. I’ve rarely seen a super physiological dose given of T3 in lab results, unless the patient takes their medication like four or five hours before you do the blood test, then you’ll see a false rise because you’re actually seeing the medication. You’re not seeing people walking aroundsuperphysiological T3 levels. Nobody would like that feeling. So anyway, I digress. Now let me pause here because this is where I need to give you some context that the FDA hasn’t quite emphasized yet. Of course, we have another connection and it is the China connection.So the FDA’s concerns about contaminated drugs and quality issues don’t exist in a vacuum. In 2024, the U.S. over 828,000 metric tons of pharmaceuticals, seven times the level from 2000. And here’s the kicker. China and India supply the majority of active pharmaceutical ingredients. APIs for U.S. generics accounting for 70 to 80 % of the total genericdrug supply. According to Reuters industry report in 2024, they state that China supplies 82 % of the APIs for critical drugs. Deb (14:08.204)Got to question that, right? Why are we giving all of our drug formulas to China and allowing them to import them into our country? In fact, roughly 20 % of the critical drugs have APIs exclusively sourced from China. And China controls 80 to 90 % of the global production for antibiotics and other key compounds. This was also cited by Reuters industry data thatcontrols 80 to 90 percent of the global production for antibiotics and other key compounds. Now just think about this. They control 80 to 90 percent of our medication. They control 20 percent of our critical drugs and we just put what kind of tariff on them? Hmm.In 2025 alone, the FDA issued multiple warning letters to foreign manufacturers for contamination issues and failure to follow good manufacturing practices. This is also cited by the FDA warning letters 2024 through 2025 and multiple citations to foreign manufacturing facilities. This is a systematic problem affecting the entire US drug supply, not just desiccated thyroid.So when the FDA suddenly became concerned about DTE quality and contamination, part of that concern was legitimate. But this is crucial. The same inconsistencies and contamination issues exist across the entire generic drug supply. And the FDA has not taken the same enforcement action against them. Let that sink in.They have not taken the same enforcement action against the other drug companies. So what’s behind all of this? Where is this all coming from? Hmm. Let’s address something directly, because you deserve to know it. And I’m going to cite my sources precisely so that when the medical boards have something to say about this, and they might, I have a documentation for every single word that I am about to speak. Deb (16:24.878)According to the court documents filed in October 2025, in the case ofa urine, a urine. I’m going to say that wrong. Pharmaceuticals versus Dr. George Tidmarsh from ABBV, the multinational pharmaceutical company that manufactures armor thyroid, reportedly petitioned the FDA in 2024, asking the agency to reclassify DTE as a biologic and to prohibit other manufacturers from selling unlicensed DTE products unless they havehad an investigational new drug application, we call this an IND, and a clinical development program aimed at eventual approval. This is cited in the court filing a Urena pharmaceuticals lawsuit versus Dr. George Tidmarsh, October 2025, reported by Fierce Pharma. Now let me explain why this matters and why this is one of the most brazen examples of regulatory capture I’ve ever seen in my career.AbbeVee is one of the world’s largest pharmaceutical companies. In 2024, they reported over $54 billion in revenue. Drop the mic on that one.They have the resources, the regulatory expertise, the legal teams, and the financial capacity to navigate a biologics license application process that costs between $500 million and $1 billion. Let that sink in. Deb (18:07.882)A drug that’s been on the market since the 1800s that was grandfathered in 1938 that’s making plenty of money right now. They’re going to spend 500 million to $1 billion to get a biologics license application. Why would they do that? Well, we’re about to find out. Most otherDTE manufacturers, smaller companies like Acela Pharmaceuticals, which makes NP-thyroid, and RLC Labs, which made WP-thyroid, do not have those same resources. And this is cited in Pharma Voice in 2025. Why a treatment older than the FDA is getting new regulatory scrutiny. So when you petition the FDA to reclassify a drug in a way that requires this type of expensivetime-consuming biological approval, you’re not just asking for safety. You’re asking to eliminate your competitors from the marketplace. Now, I want to be very precise here. These allegations are documented in federal court filings, and it hasn’t been approved in court. It’s also been reported by multiple industry sources, including Fierce Pharma. But I’m telling you,what has been reported in legal proceedings, not stating it as an absolute fact because you deserve to know the difference and because I have to protect my license. Now, what do we know for certain?AbbeVee is working on a biologics license application for Armour thyroid through clinical trials called Avantia. This is cited by the AbbeVee corporate statement 2025 Avantia clinical trial for Armour thyroid. A cell of pharmaceuticals has been pursuing BLA approval for NP thyroid for seven years since 2017 and it completed its phase two trials successfully in 2025. They’re now moving Deb (20:15.448)into Phase 3 trials. This is also cited by the Acela Pharmaceuticals CEO statement 2025 seven-year pursuit for BLA approval completed Phase 2 trials moving to Phase 3.RLC Labs, which manufactured WP thyroid, has made no public announcement about pursuing BLA approval and really probably don’t have a plan to do this since they’ve been off the market for some time now. About five years, I think maybe a little longer. Here’s the market manipulation.If only ABBV is successful and obtains a BLA approval for Armour thyroid, that company would effectively have a monopoly on the DDT market. And in pharmaceutical markets, monopolies historically lead to price increases.We’ve seen this pattern over and over again when turning pharmaceuticals acquired Daraprim and raised their price from $13.50 to $750 per tablet overnight. When Myelin raised EpiPen increased prices by 400 % when insulin manufacturers colluded to raise prices in lockstep. This is the playbook.use regulatory barriers to eliminate your competition and then exploit pricing power. For a drug that’s been on the market since the 1800s, guess corporate greed is everywhere. They’re not making enough money on this product already and they’re taking advantage of the rules that they can manipulate their competition by. And here’s what really makes me furious. The American Thyroid Association, the professional organization Deb (22:06.672)representing endocrinologists sent letters to the FDA commissioner on October 8th of 2025 and September 18th of 2025.advocating for continued patient access to DTEs. This is cited in the American Thyroid Association statement and letter to the FDA commissioner dated October 8th, 2025 and September 18th, 2025. The American Association of Clinical Endocrinologists issued a statement on September 9th of 2025 supporting equitable access and personalized medicine for DTE. This was also cited in the American AssociationAssociation of Clinical Endocrinologists, AACE, statement dated September 9th, 2025. Even the medical establishment, which has historically favored levothyroxine, is saying, wait, this is going too far. Patients need access to this medication. But the FDA is moving forward anyway. Why? Well, where does it always lead us? Follow the money trail.Okay, so I need to explain what a biologics license application actually is because this is where the rubber meets the road for what’s going to happen to pricing and availability. What is a BLA?A BLA is a biologics license application. It’s a formal request submitted to the FDA to market a biologic product in the United States. A biologic is defined under the Public Health Service Act section 351 as a product derived from or made using living material, in this case, animal thyroid glands. And this is cited in the FDA definition for biologic products. So they’re putting armor thyroid right Deb (23:57.377)right up with stem cells and exosomes. Think about that. Stem cells and exosomes cost thousands of dollars per application because of how they have to be harvested, stored, freezed, all of that. But we’re talking about a thyroid gland. Good Lord, people.Unlike regular drug applications for synthetic medications which follow a simpler pathway, the BLA process is designed for complex biological products like monoclonal antibodies, vaccines, and gene therapy products. It’s a much more expensive, much more time-consuming process. The BLA processis what manufacturers have to do. And we’re going to talk about that. So according to Reprocell and Forge Biologics analysis of the FDA’s BLA process, here’s what companies need to submit. First, they need to complete a clinical trial data, phase one, two, and three trials, proving safety and efficacy for desiccated thyroid. Haven’t we done that since it’s been on the market since the 1800s? Just saying.This means they have to conduct large randomized controlled trials comparing it to levothyroxine, measuring safety outcomes, efficacy outcomes, and quality of life metrics. Second,Chemistry, Manufacturing and Controls, CMC’s data. Detailed information about how the product is manufactured, quality control measures, stability testing and specifications that must be met for every batch. Third, preclinical and animal safety data. Fourth, labeling and product information. Now, I think we have labeling and product information. Deb (25:53.717)since the 1800s? But just saying. Fifth, they need Pharma Covigilance Plan, a detailed plan for monitoring safety after the product is on the market. Haven’t they had to do that since the 1800s? And they have to have a timeline. And this is the critical part. The FDA’s standard review time for a BLA is 10 months.That’s after the application is deemed complete and accepted for filing. So this is cited by the FDA standard review timeline, BLA submission, and FDA review.Now, before you even get to filing, you need to conduct the clinical trials and compile all the data that’s typically several years of work. How are you going to prove safety and effectiveness in a large clinical trial long term? What do they consider? What do they deem long term? Three months, six months, a year, two years. These companies had 10 months.Well, maybe 12. They did it a year in advance. But unless you knew this was coming, how are you going to put together a trial, enroll the people, have all the trial components set up and ready to go in less than 12 months unless you knew it was coming beforehand? Even ifhad started all their clinical trials in 2024, completing them, compiling the data, and getting a complete application ready for submission, this would likely take you through mid-2026, then add another 10 months for FDA review. We’re looking at 2027 at the earliest for most of these companies to receive a BLA application. Deb (27:54.319)But the FDA gave the manufacturers until August of 2026. That’s approximately 19 months from when the August 2025 letters were sent. Most companies cannot reasonably complete the BLA approval in that timeframe. And when I’m talking about the 19 months, I’m talking about the information they would have had earlier. Now the cost.This gets me even more frustrated. Why are we spending this kind of money? The BLL process is extraordinarily expensive. The current FDA user fee for a BLA submission is approximately $483,560 just for the filing fee. And this is cited at the FDA user fees prescription drug user fee rates for 2025.The full cost of conducting clinical trials, CMC studies, and all the supporting documentation typically ranges from $500 million to over $1 billion, depending on the scope of the trials and the complexity. And this is cited in JAMA’s network, Open2023. A cell of pharmaceuticals has been pursuing the BLA approval since 2017. That’s eight years. And it’s just now.moving into phase three trials with a planned enrollment of approximately 300 patients. This is cited by the Acela Pharmacies CEO statement of 2025. Now that’s unusual. That’s typical for this process. This is not unusual. This is typical for this process to take seven, 10 years to get approval for this. So if Abby’s the one that requested this,Abby V. And Acela started this in 2017. Was Abby V threatened by Acela that Acela might get this approval and it would be quietly done without anybody seeing it? And maybe Abby V would be left out of the market after a century? Who knows? It’s possible. Deb (30:13.112)But for smaller manufacturers without billions in revenue, this cost is completely prohibitive. And this is why this matters. When you push an old established medication through an extraordinary, expensive approval process with a compromised timeline, one of three things happen. First, only the largest companies can afford it, creating a monopoly. And when that happens, the company that holds the only approved product can set pricing withminimal competitive pressures. Two, smaller manufacturers can’t afford it and their products disappear and the market shrinks and access decreases. Three, we see a combination of both and who pays the price? Literally, patients do. Now here’s whereThere’s something I want you to really think about because this is where the regulatory argument falls apart when you look at it carefully. The FDA’s concern about DTE is that, and I’m quoting their official statement, tablets from the same manufacturing batches may not always provide the same thyroid hormone levels. This is from their FDA statement.And that’s a legitimate quality concern, right? It is. Thyroid medications have a narrow therapeutic window like any other hormone, meaning the difference between an effective dose and the dose that causes problems can be quite small. But here’s what the FDA doesn’t emphasize. Generic drugs have the exact same dosing inconsistency issue, and it’s considered acceptable and has been since we allowed generics on the market.So how does a generic drug dose work anyway? Well, for generic drugs to be approved as bioequivalent to a brand name medication, the FDA requires that the generic drugs bioavailability fall within 80 to 125 % of the brand name product. Isn’t that a dose inconsistency? Deb (32:22.894)from the brand name medication? 800 or sorry, 80 to 125%. According to the pharmacy times analysis of the FDA’s bioequivalent standards, the 80 to 125 % bioequivalence rule means that a generic drug can have 20 to 45 % variability compared to the original brand product.Now, most generics are much closer than that. The FDA study data shows that the mean difference for an AUC value between generic and reference products is about three and a half percent in the two year post-Waxman hatch period, and 80 % of the generics fall within a five percent range. But the FDA’s regulations allow for that much higher variability. And this is cited in an FDA study data mean difference for AUC.Now, let me put this in plain language. A patient could take a generic levothyroxine tablet where one batch provides, say, 75 micrograms of an active thyroid hormone. And the next batch from a different manufacturer, a different generic manufacturer, could provide up to 93.75 micrograms, 125 % of that 75. That’s an 18 microgram difference.in the same prescribed dose. Now, this is considered acceptable and patients tolerate it and this system works.Yet the FDA’s argument against DTE is that batch-to-batch inconsistency is unacceptable and requires this expensive biologic approval? That’s a double standard. So why is batch inconsistency acceptable for generic levothyroxine, but supposedly unacceptable for desiccated thyroid? I’ll give you the regulatory answer. Deb (34:29.366)because DDT is a biological product derived from an animal tissue and the FDA considers biological products to require more rigorous control. That’s the regulatory answer, but I’ll give you the real answer.because there’s no billion dollar pharmaceutical company with a patent pending on generic levothyroxine who petitioned the FDA to regulate their competitors more strictly. The inconsistency argument is legitimate, but it’s selectively applied. And that matters when you’re trying to understand whether this is really about patient safety or whether it’s about market control.Now I want to talk about something that hasn’t gotten nearly enough attention in this discussion and it’s something that makes me absolutely furious. What is Armour Thyroid? According to the official prescribing information published by AbbeV and available through rxabbev.com and the FDA’s daily med database, Armour Thyroid contains the following inactive ingredients. Calcium steroid,dextrose derived from corn, mycocrystalline cellulose,sodium starch glycolate and a opadri white coating. Now let’s talk about dextrose. Dextrose is a sugar derived from corn and while manufacturers claim that the corn derived dextrose in armor thyroid is gluten free, here’s the problem. Cross contamination during corn processing can introduce gluten proteins especially if the corn is processed in facilities that also handle Deb (36:18.808)wheat, barley, or rye. Corn sensitivity is extremely common in patients with celiac disease and non-celiac gluten sensitivity, and studies show that up to 50 % of the celiac patients react to corn proteins due to molecular mimicry, and the corn proteins look similar enough to gluten that the immune system attacks them. And this is cited by RestartMD.com.And here’s what’s documented in peer-reviewed medical literature in a 2023 case report published in Case Reports in Endocrinology. These researchers documented five patients with gluten intolerance or celiac who were taking natural desiccated thyroid. Three of those patients also reported lactose intolerance. Now these patients had to switch from DTE to liquid levothyroxine formulations to avoid the inactiveSo here’s my question. If AbbeV becomes the only manufacturer with an approved DTE product and their formulations contain corn-derived dextrose that triggers reactions in celiac patients, what are those patients supposed to do? They can’t take armor because of the corn. They can’t take compounded DTE because the FDA is banning compounding of these biologics. They can’t take NPKsor WP thyroid because those companies may not survive the BLA process. So they’re left with a synthetic version of levothyroxine which may not work for them.Now the NP thyroid and WP thyroid difference. Now here’s what’s interesting according to drugs.com comparison of inactive ingredients and P thyroid and P thyroid has calcium steroid dextrose also derived from corn, mineral oil, multi-crystalline cellulose. Deb (38:19.31)cross carmelicin sodium and a opadri to white. So NP thyroid also has corn-derived dextrose. WP thyroid on the other hand was specifically formulated to be hypoallergenic according to ROC labs, but it’s no longer available and its ingredients were inulin from chicory root and medium chain triglycerides. No corn, no gluten, no common allergies. So todayWe do not have a glandular thyroid, a DTE, that is not potentially contaminated with gluten. Yet, patients with autoimmune thyroid disease are supposed to avoid gluten.Now, some of these people can handle a DTE and many cannot, so that argument could be a mute point. But at the end of the day, the one product that we had that was designated for patients with multiple chemical sensitivities, celiac disease and coron allergies, has been off the market for a long time already.We have a monopoly problem. So if ABBV becomes the only approved manufacturer, patients with these celiac diseases and corn allergies will either be forced to take a medicine that makes them sick and triggers their immune reaction or switch to a synthetic that doesn’t adequately treat their hypothyroidism or choose to go without treatment. This is not hypothetical. This is real patients with real medical needs who are about to lose accessto the only formulation that works for their body. And the FDA’s response is silence. Deb (40:07.69)Now I want to highlight something that hasn’t gotten nearly enough attention in this discussion. Compounding pharmacies. What is a compounding pharmacy? Compounded medications are custom made by licensed pharmacists to meet a patient’s specific needs. Maybe you need a different strength that was commercially available, but you have an allergy to a filler or a dye in the commercial product. Maybe you need a liquid formulation or instead of a tablet or you need a capsule. That’s when compoundingin. And the FDA’s, this is the FDA’s definition of compounding. And for decades, compounding pharmacies have been making desiccated thyroid extract for patients who needed customization. Some patients couldn’t take the commercial products because of the dyes and the fillers, and some needed strengths that were not available. And these compounding pharmacies filled the gap.But reclassification changes everything. When the FDA reclassified DTE as a biologic in 2022 and reinforced that decision in August of 2025, explicitly stated, and I’m quoting directly from the FDA’s official statement, these unapproved animal-derived thyroid medications are not eligible for compounding because these products are regulated as biologic products under the Public Health Service Act.How can that be? These products have been approved since 1938 and the Biologics Act didn’t go into effect or doesn’t go into effect until August of 2026.So how in 2022 were they able to say that the compounding pharmacies could not make these products? Anyway, what this means is after August 2026, compounding pharmacies will no longer be permitted to compound a desiccated thyroid extract, even for patients with specific medical needs. Now, compounding pharmacies can still compound T4 and T3 separately, synthetic versions of levothyroxine and liothyronine, according to Deb (42:12.728)healing dose compounding pharmacy. These pharmacists can create custom ratios of these two synthetic hormones to approximate what a patient was receiving from a DTE. But that’s not the same thing. Some patients respond better to the whole DTE preparation than to a compounded synthetic combination. And for patients with specific allergies to standard fillers like your celiac patients that I just talked about, losing the ability to get a compounded DTE alternative isreal hardship. This is going to be a ripple effect. For a subset of patients, maybe 5 to 10 percent of those on DTE compounding was their lifeline and it was their way to get a medication formulation that worked for their unique body. When compounding goes away, these patients lose that option as well and for some it will be a significant problem. Now let’s talk about what this likely means for your wallet.The current pricing right now, according to SingleCare and GoodRx, Armour Thyroid costs approximately $150 to $157 for a 90-day supply of 60-milligram tablets, about $1.67 per tablet. With discount cards, some patients can get it down to $101 to $152 for a 90-day supply.Generic levon thyroxine costs about $70 for a 90 day supply, less than half that price. And p-thyroid costs approximately $133 for a 90 day supply of 60 milligrams with a discount card about $83 to $101.What happens after we get BLA approval? Well, here’s the pharmaceuticals pricing model. When a company spends 500 million to $1 billion to bring a product to market, including conducting massive clinical trials, the cost tens of millions of dollars they recoup in that investment through pricing power. And this is cited in the pharmaceutical pricing models. If ABBIEV is the only company with an approved BLA of DTE, Deb (44:18.248)They have pricing power. They don’t have competitors. They can set their price, whatever they want. And historically, when drugs transition from grandfather status, which is basically unregulated to formal formally approved status, prices often increase significantly, not always, but often. And typically they have to get re-approval for insurance. SoTouring Pharmaceuticals acquired DARPM and raised the price again from $1,350 to $750 overnight, a 5,000 % increase. This is the playbook.Let’s talk about insurance coverage. This is the other consideration. Insurance companies sometimes have different coverage policies for approved versions versus unapproved drugs. And right now, many insurance plans cover armor thyroid or NP thyroid, even though they’re technically unapproved because they’ve been on the market for decades and patients are on them. Once a drug becomes formally approved, insurance companies may have new contractual relationships, prior authorization requirements, or preferred drugs.list that could affect your coverage. If 1.5 million people have to get a prior auth for their insurance to cover this new medication, this is going to drive the doctor’s offices crazy. We do not have the staff to man this. We do not have the manpower. We do not have the time. This is going to interrupt people’s ability to get their medications. This is going to create chaos within the system. And some patients might see better coverage, but manymost likely are going to see worse coverage and some might find themselves in a situation where they need to try to get the drug approved first or get an approval for something else like levothyroxine and they’re going to have to document that it didn’t work and the documentation that they had from 20 years ago is probably not going to be enough because it’s not documented anywhere. It’s lost in the system after 10 years. So for patients the practical takeaway is expect Deb (46:25.774)a price increase. I would say possible, but I don’t think that’s true. think you’re going to see a price increase if they get approved. Expect possible insurance complexities, budget accordingly, talk to your insurance company now about what your coverage is going to look like in 2027 if they even know. And if you want my honest assessment of what is likely to happen,I’ll give you a scenario, 30 % likelihood. The FDA enforces the August 26 deadline and DTE products not approved by then are pulled from the market. Patients will have 30 to 90 days to transition to other medications. Some patients suffer significant symptom relapse. Compounding for DTE becomes illegal and this disruptiveness of the system creates a real hardship. Scenario two.which is 50 % likely. This is actually what the FDA commissioner, Marty McCreary suggested on August 13th of 2025 when he posted on social media. The FDA is committed to pursuing the first ever approval of desiccated thyroid access pending results of the ongoing clinical trials. In the meantime, we’ll ensure access for all Americans. Hopefully that continues. What this likely means is the FDA uses enforcement discretion to allow continuedsales while approvals are being pursued and the deadline gets extended. Maybe patients get access for another two to three years while companies work on a BLA approval. This would be the least disruptive scenario, but it’s also legally uncertain because the enforcement letters have been formally rescinded. And scenario three, which is 20 % likelihood, one or two companies get BLA approval. Those products stay on the market at higher product prices and companies, products, other companiescompanies, products are pulled, the market shrinks, availability is limited, prices are higher, but patients can still get something. This is likely if a seller successfully completes phase three trials for NP-thyroid. And my assessment is based on the regulatory language and the enforcement letters that have not been rescinded yet, that the pattern of FDA enforcement, I believe scenario two enforcement discretion with an extended time frame is most likely what we’re going to see. Deb (48:49.488)doesn’t mean patients should sit back and do nothing. It means you should be prepared for change while advocating for access. If you want to keep Arm or Thigh Right on the market, 1.5 million people need to start talking about this publicly and flooding our Congress people, Bobby Kennedy, the FDA, with what you want to see happen. We have the ability to shape this and to change this with our voice. But if we sit back on our laurels and we do absolutelynothing. What is going to happen is what the FDA wants to have happen and ABV wants to have happen because they’re going to simply think people don’t give a shit. And if the American people are going to be lazy and not want to step forward and actually start using their voice for some good and instead of just going to social media and bitching and hoping something is going to happen, well, then we’re going to get what we deserve. But if you start taking someaction and you start advocating for the things that you want. Contacting your representatives, contacting your U.S. tell them the FDA has done this. Many of them may not know this, may not be on their radar. Tell them what you want. Start going after this. Start writing to the FDA Commissioner’s Office. They have a website. They have a Commissioner’s Office at fda.hhs.gov. Be responsible.respectful, but be firm. Explain your scenario. How long you’ve been on DTE. Why levothyroxine doesn’t work. What symptoms you experience when not adequately treated. How this decision will affect your quality of life and your pocketbook. Let’s do something proactive. So let’s consider this. Moving forward, work with your provider who understands the regulatory landscape around DTE. You can discuss the evidence for and against combination therapy.You can monitor for thyroid function with free T3 and free T4 testing, not just TSH. If you’re willing to try individualized approaches, you can do that. If you need help finding a functional medicine provider who understands this issue, come to serenityhealthcarecenter.com or explorethevanari.com. It’s a self-directed functional medicine support group. And right now what is happening is going to shape how history Deb (51:19.024)is made with not just armor thyroid, but many drugs to come. And it is important for you to take action. So I want to thank you for joining me today on Let’s Talk Wellness Now. This episode is about far more than thyroid medication. It’s about your right to personalized medical treatment. It’s about your regulatory capture and corporate influence. And it’s about what happens when billion dollar companies shape healthcare policy in ways that reduce patient choice and increase their profits.this episode resonates with you or you know somebody who’s going to be affected by desiccated thyroid, please share it. Post it on social media, send it to your doctor, email it to your representatives, tag AbbeVee, tag FDA. Make noise because the only way we stop this is if we make it too politically costly for them to continue. Your voice truly matters. Your health truly matters and you deserve access to treatments that work best for your unique body.If you’re ready to explore comprehensive personalized health care that puts you in control, visit us at SerenityHealthCareCenter.com. Learn more about functional medicine approaches to thyroid and beyond and explore my new platform, Venari.com, which is a self-directed functional medicine tool. Thank you for joining me today. Until next time, I’m Dr. Deb reminding you, your health is your responsibility, your choice, and your right. Be well, stay informed, fight back.and I’ll see you in the next episode. And if you’re looking for a full citation list of this episode, you can head over to letstalkwellnessnow.com and I will post all the citations for you so you have them in your arsenal as well. Thank you again.The post Episode 259 – The Desiccated Thyroid Crisis: FDA's Unseen Impact & Corporate Manipulation first appeared on Let's Talk Wellness Now.

God and Guns Podcast GNG 366 - Remembering Chuck Norris   Intro: Welcome back to Episode 366 of the God and Guns Podcast . I'm your host, Troy. (Doug) And I'm your other host Doug. (Troy) We use this podcast to talk about  God, guns, and the responsible Christian gun owners' interests. On this week's God and Guns Podcast we will be remembering Chuck Norris.   Want to thank our sponsors:  Bandwidth Sponsor:   Firearms Radio Network - Other Shows - Content   Patriot Patch Co   This Week's God and Gun activities: Doug: God: Church Sundays, sportsman daily devotional   Guns: EDC . Been working long hours this week as we kicked off a huge project at work. Truck is in the shop since monday. May get it back next week. Got a rental car and they gave me a chevy malibu. Now I know why I am a truck guy.  Cant do any ham radio since my radio is in the truck and haven't been on HF at all this week.   Troy: God: Daily Bible Reading, Church, Church Security   Guns: ordered and received some more Magpul AR-15 Mags from PSA  and some Black Hill's 5.56 77gr ammo, Also more 300BO 220gr Subsonic.    Family: girls bath remodeled We are waiting for them to wrap up so we can return to KY.    Farm: Not much right now   Ham: Heading to Stuart Hamfest tomorrow. Reprogrammed my SharkRF M1KE EDC Check: Troy: Shadow Systems XR920n a Crossbreed Super-Tuck Holster, using a STOG Enhanced Life Saver, Sof-T Tourniquet, steam light    Doug:  Sig P365 with Romeo Zero optic . Hornady critical duty ammo. Benchmark OTF.    Feedback:  ITunes   Comedy Best Chuck Norris jokes and sayings Chuck Norris doesn't wear a watch. He decides what time it is. Chuck Norris cannot turn left, because he is always right. Chuck Norris doesn't read books. He stares them down until he gets the information he wants. Chuck Norris doesn't tip the waiter. The waiter tips him. Chuck Norris' tears cure cancer. Too bad he has never cried. Chuck Norris does not own a stove, oven or microwave, because revenge is a dish best served cold. If rock beats scissors, scissors beats paper, and paper beats rock, what beats all 3 at the same time? Chuck Norris. Time waits for no man, unless that man is Chuck Norris. When Chuck Norris left home, he told his father: "Your the man of the house now." Chuck Norris destroyed the periodic table, because Chuck Norris only recognizes the element of surprise. Chuck Norris doesn't do a push up. He pushes the world down. Chuck Norris has to sleep with the lights on because the dark is afraid of him. When the bogeyman goes to sleep, he checks under his bed for Chuck Norris. When Chuck Norris goes swimming, sharks get out of the ocean. Clouds don't rain. They sweat when they see Chuck Norris. Chuck Norris doesn't worry about high gas prices. His vehicles run on fear. When Chuck Norris cooks, he makes the onion cry. Chuck Norris can sneeze with his eyes open. When Chuck Norris looks in a mirror, the mirror shatters. Because not even glass is dumb enough to get in between Chuck Norris and Chuck Norris Ghosts tell Chuck Norris stories at the campfire. Chuck Norris counted to infinity. Twice.  Outer space exists because it's afraid to be in the same planet with Chuck Norris. Chuck Norris beat the sun in a staring contest. Once a cobra bit Chuck Norris' leg. After five days of excruciating pain, the cobra died. Chuck Norris can divide by zero. Chuck Norris' calendar goes straight from March 31 to April 2. No one fools Chuck Norris. There is no theory of evolution, just a list of creatures Chuck Norris allows to live. Chuck Norris can start a fire by rubbing two ice cubes together. If you spell Chuck Norris in Scrabble, you win. Forever. Chuck Norris can do a wheelie on a unicycle. Chuck Norris can fold a fitted sheet. When Chuck Norris makes a mistake, the mistake apologizes. Fire doesn't burn Chuck Norris. Chuck Norris burns fire. Chuck Norris doesn't need a keyboard. He tells the computer to write something and it does. Chuck Norris has already been to Mars. That's why there are no signs of life. Chuck Norris doesn't get sun burnt. That would be a foolish thing for the sun to do. There is no chin underneath Chuck Norris's beard. There is only another fist. The sun rises and sets according to Chuck Norris's sleep schedule. Chuck Norris got pulled over by police once. He let the cop go with a warning. Chuck Norris doesn't have to mow his lawn. The grass is afraid to grow. The only time Chuck Norris was wrong was when he thought he made a mistake. When Chuck Norris looks in the mirror there's no reflection, because there's only one Chuck Norris. Chuck Norris had a stunt double. He was used for crying scenes. Chuck Norris didn't dial the wrong number. You picked up the wrong phone. They once named a street after Chuck Norris, but they had to change the name because nobody crosses Chuck Norris and lives to tell about it. Chuck Norris built the hospital he was born in. Chuck Norris caught COVID-19. Now the virus has to quarantine. How many push-ups can Chuck Norris do? All of them. Legends live forever. Chuck Norris lives longer. Chuck Norris didn't die. Death finally had the courage to meet him. Honorable mentions: Nevada-related Chuck Norris jokes Chuck Norris once played blackjack in Reno. The cards folded themselves before he even sat down. Area 51 doesn't hide aliens from the public. The aliens hide there from Chuck Norris. Before Chuck Norris went to Virginia City, it was just called the Bucket Saloon. The Hoover Dam doesn't hold back water. It holds back Chuck Norris's disappointment. Chuck Norris has walked through several Nevada towns. Now they're “ghost towns.” Via Reno Gazette-Journal   On this day in History: 1727 Sir Isaac Newton died in London at the age of 40. Newtonian physics   Bible Verse 2 Corinthians 4:16-18 ESV So we do not lose heart. Though our outer self is wasting away, our inner self is being renewed day by day. For this light momentary affliction is preparing for us an eternal weight of glory beyond all comparison, as we look not to the things that are seen but to the things that are unseen. For the things that are seen are transient, but the things that are unseen are eternal.   Main Topic Remembering Chuck Norris   Carlos Ray "Chuck" Norris was born on March 10, 1940, in Ryan, Oklahoma. He was a renowned martial artist, actor, and author, famous for his roles in action films and the television series "Walker, Texas Ranger," and he also founded his own martial arts system called Chun Kuk Do.  Oklahoma Historical Society Wikipedia Early Life Carlos Ray "Chuck" Norris was born on March 10, 1940, in Ryan, Oklahoma. He was the eldest of three brothers. His father, Ray Norris, served in World War II and later worked various jobs, while his mother, Wilma, had Irish ancestry. At age 12, Norris moved to Torrance, California, where he later joined the United States Air Force in 1958.   Martial Arts Career Norris began training in martial arts while stationed in South Korea, where he learned Tang Soo Do. He became a successful martial artist, winning numerous championships, including the World Professional Middleweight Karate title for seven consecutive years. In 1990, he made history as the first American to achieve the rank of 8th Degree Black Belt Grand Master in Taekwondo.   Acting Career Norris made his film debut in "The Wrecking Crew" (1968) and gained fame through action films like "Way of the Dragon" (1972) alongside Bruce Lee, and the "Missing in Action" series starting in 1984. He starred in the popular television series "Walker, Texas Ranger" from 1993 to 2001.   Personal Life and Legacy Norris has been married twice and has five children. He is a devout Christian and has written several books on martial arts, philosophy, and self-help. He became a cultural icon with the "Chuck Norris facts" internet meme, which humorously exaggerated his toughness. Norris passed away on March 19, 2026, at the age of 86, leaving behind a legacy as a martial artist, actor, and author.   Show Sponsor: Patriot Patch   How you can help out the show: Patches and Stickers Using the following links help support our show. Subscribestar GodandGuns you have to set up for repeat donation if you want it monthly. www.subscribestar.com/god-and-guns Powertac Lights - godandguns Crossbreed Holsters - GNG Armed Citizen Armed Citizen® Today On Jan. 23 in St. Petersburg, Fla., around dinnertime, two men were sitting in a vehicle when two other men approached and reportedly tried to rob them at gunpoint. The robbery victims were also armed, however, and one or both of them responded by shooting at the alleged assailants. One of the robbery suspects died and the other was critically wounded. Police detained all involved but said the incident appeared to be self-defense. (fox13news.com, Tampa Bay, Fla., 1/24/26)   From the Armed Citizen® Archives – January 1989 An 89-year-old Ft. Wayne, Ind. woman was talking on the phone when the line went dead. Later, she heard noises and thought someone was trying to break in. So she headed out the door to a neighbor's house to call the police. But, as she opened the door, a man wearing a black hood pushed her back into the house. Her 91-year-old husband heard the commotion and grabbed a shotgun. The hooded man told the husband to get back, but when the resident continued to advance, the hooded man fled. “The gun saved us,” the woman said. “Boy, did he run.” (The News Sentinel, Fort Wayne, Ind.)     Wrap Up: -Send feedback to GodandGunsTV@gmail.com -Please tell your friends about us,